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ABSTRACT 
The current understanding of human germ cell development is limited and is at most parts 
extrapolated from studies of mice or other model organisms. Particularly, the specification 
events of human germ cell lineage are largely unknown, which is at least in part due to 
inaccessibility of early stages of human development. In addition, debate on the existence of 
oogonial stem cells (OSCs) in adult ovaries further indicate that more research is needed in 
order to elucidate human germ cell development. 
Human pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSCs), offer a promising in vitro strategy to study fundamental 
questions regarding human germ cell development and to model genetically caused infertility. 
In this thesis, we used human PSCs to elucidate the genetic requirements of human germ cell 
development. Specifically, we assessed the potential of human iPSCs to differentiate to pre-
meiotic and post-meiotic germ cells, studied the function of germ cell specific NANOS3 and 
Deleted in azoospermia like (DAZL) proteins via over expression in hESCs, and optimized 
clinically relevant iPSC reprogramming conditions for the derivation of patient specific 
iPSCs from fibroblasts of infertile Klinefelter syndrome (KS) patients. Furthermore, we 
studied the existence of OSCs by isolating and characterizing cells from adult human and 
mouse ovaries.   
We found that human iPSCs derived from fetal- and adult somatic cells could differentiate to 
pre-meiotic germ cells with similar or higher efficiency relative to hESCs. Furthermore, in 
response to the over expression of intrinsic meiotic regulators, we observed that like hESCs, 
iPSCs formed meiotic and post-meiotic haploid cells. In addition, we identified several 
candidate genes for NANOS3 and DAZL mediated functions by over expression in hESCs. 
We found that human NANOS3 may have a conserved role in suppression of differentiation 
and inhibition of apoptosis, and DAZL in induction of germ cell differentiation and cell cycle 
arrest. Furthermore, we identified a possible new role of DAZL in inhibition of cell 
migration. For optimizing clinically relevant iPSC reprogramming conditions, we achieved 
efficient reprogramming using xeno-free and chemically defined laminin-521 and NutriStem 
medium, and derived KS patient specific iPSCs. Finally, we contradicted the previous study 
of OSCs by showing that the reported DEAD (Asp-Glu-Ala-Asp)-box polypeptide 4 (DDX4) 
antibody –based isolation of OSCs did not select for DDX4 expressing cells from adult 
human or mouse ovaries, and the isolated cells were not functional OSCs. 
In conclusion, human PSCs have an enormous potential to elucidate the complex mechanisms 
of human germ cell development, and may ultimately contribute to new strategies for the 
diagnosis and treatment of infertility in years to come. In addition, we found no evidence for 
the existence of OSCs in adult human ovaries, thus, supporting the central dogma of fixed 
ovarian reserve. 
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1 INTRODUCTION 
Germ cell development has been comprehensively studied in mice, but very little is known in 
the human. Particularly, the molecular and cellular events leading to specification of the germ 
cell lineage in embryonic development are largely unknown due to the inaccessibility of early 
human embryos. Although spermatogenesis and oogenesis, occurring in adulthood, are more 
extensively studied, our knowledge on the maintenance of spermatogenesis by a stem cell 
population is still limited. Furthermore, recently emerged debates on the existence of 
oogonial stem cells (OSCs) in adult mammalian ovaries show that more research is needed to 
examine the specifics of human germ cell development.     
Human pluripotent stem cells (PSCs) offer a great strategy to study fundamental questions 
regarding human germ cell development, including the molecular pathways and genetic 
requirements for germ cell formation. In addition, the revolutionary technology of induced 
pluripotent stem cell (iPSCs) reprogramming enables the derivation of patient specific PSCs 
providing an in vitro platform to model infertility, and in years to come may lead to a new 
form of assisted reproduction.   
1.1 PLURIPOTENT STEM CELLS 
PSCs are undifferentiated cells that are capable for unlimited self-renewal and differentiation 
into any type of cell representing the three embryonic germ layers: endoderm, mesoderm and 
ectoderm, as well as the germ line. These specific characteristics make PSCs a powerful tool 
to study cell lineage commitment and early development. Furthermore, PSCs have a great 
potential to be used as a treatment for degenerative diseases. In fact, two clinical trials using 
PSCs as a treatment are currently ongoing for spinal cord injury and age-related macular 
degeneration (1, 2).      
1.1.1 Human embryonic stem cells 
Human embryonic stem cells (hESCs) are PSCs that are derived from left over or poor 
quality embryos produced by in vitro fertilization (IVF) for clinical purposes (Figure 1). The 
inner cell mass (ICM) of a blastocyst stage embryo is isolated and placed into culture 
conditions that support undifferentiated cell proliferation, resulting in the derivation of a 
stable hESC line (3). Derivation of the first hESC lines was reported in 1998, and ten years 
after, over one thousand new hESC lines had already been described (4). The derivation 
technique and culture conditions have been improved over the years, and now it is possible to 
derive hESCs also from a single blastomere of a morula (8-10 cell stage embryo), without the 
need to destroy the embryo (5, 6).  
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Figure 1. Human pluripotent stem cells. Various types of human somatic cells can be reprogrammed to induced 
pluripotent stem cells (iPSCs) by transient expression of pluripotency factors. Human embryonic stem cells 
(ESCs) can be derived from the inner cell mass of a blastocyst stage embryo or from a single blastomere of 8-
cell stage embryo. 
1.1.1.1 Characterization 
The characteristic morphology of hESCs is a high nucleus to cytoplasmic ratio and prominent 
nucleoli, and they form relatively flat, compact colonies with distinct cell borders (3). hESCs 
can be cultured for extended time periods, while retaining their pluripotency and normal 
karyotype. The criteria to assess pluripotency include a set of cell surface markers and 
transcription factors, and the capacity to differentiate in vitro and in vivo (7). 
Standard cell surface markers that are expressed by hESCs, include stage-specific embryonic 
antigen (SSEA) 3, SSEA4, tumor-related antigen (TRA)-1-60, TRA-1-81 and alkaline 
phosphatase (AP) (3). The expression of other stem cell related cell surface markers has also 
been described for hESCs, such as CD9 and v-kit Hardy-Zuckerman 4 feline sarcoma viral 
oncogene homolog (KIT) (8). Core transcription factors POU class 5 homeobox 1 (POU5F1, 
also known as OCT4), NANOG and SRY (sex determining region Y)-box (SOX) 2 are 
required for pluripotency and self-renewal of hESCs, and are routinely used in the 
characterization of hESCs (9).  
The potential of hESCs to differentiate towards the three germ layers is analyzed by in vitro 
and in vivo assays. Upon injection into severe combined immunodeficient (SCID) mice, 
hESCs form teratomas, which contain cells of endodermal, ectodermal and mesodermal 
origin (3). A comparable in vitro assay is the formation of cell aggregates called embryoid 
bodies (EBs), which contain spontaneously differentiated cells from all three germ layers 
(10). These two methods are most commonly used for the characterization of new hESC 
lines, however, for using hESCs as a model for developmental studies, directed 
differentiation to a specific cell lineage is preferred. Efficient differentiation protocols for 
obtaining e.g. midbrain dopamine neurons, hepatocytes, and cardiomyocytes have been 
reported (11-13). The differentiation of PSCs towards the germ line is discussed in section 
1.6.   
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1.1.1.2 Culture conditions 
The first hESC lines were derived on mitotically inactivated mouse embryonic fibroblasts 
(MEFs) as feeder cells, and using culture medium containing fetal bovine serum (FBS) (3). 
These undefined culture conditions, however, create variability and expose hESCs to 
xenogeneic components. For possible clinical use of hESCs or their derivatives, good 
manufacturing practice should be followed, including defined culture components and 
minimal exposure to animal-derived substances (14).  
The animal-derived MEFs can be substituted with human cells, and FBS with knockout 
serum replacement (KSR) and basic fibroblast growth factor (bFGF), although KSR is not 
completely devoid of animal substances (15-17). In the absence of serum, bFGF is needed for 
the undifferentiated self-renewal of hESCs, and it has now been well established that bFGF 
signaling is required for hESC maintenance (18).  
For the establishment of feeder-free cultures, several matrix proteins have been used for 
coating of culture plates. Matrigel, a mouse tumor extract containing a mixture of proteins, is 
most commonly used with either a conditioned medium collected from MEF culture plates or 
commercially available mTeSR1 medium containing a high concentration of bFGF (19, 20). 
Xeno-free derivatives of the mTeSR1 medium have been used to establish completely xeno-
free and feeder-free culture conditions, using either a mixture of collagen IV, vimentin, 
fibronectin and human placenta laminin, or human recombinant laminin-511 alone (20, 21). 
Passaging of hESCs has conventionally been done in small clusters of cells either manually 
or enzymatically (3, 16). The poor survival of hESCs after dissociation into single cells has 
limited the manipulation of the cells, however, Rho-associated coiled-coil kinase inhibitor 
(ROCKi) was found to increase the cell survival of dissociated hESCs and facilitated the use 
of hESCS in several applications, including gene transfer and cell sorting (22, 23). Recently, 
human recombinant laminin-521 together with chemically defined and xeno-free medium 
NutriStem were shown to support the culture of single-cell dissociated hESCs without the use 
of ROCKi, and furthermore, laminin-521/E-cadherin matrix allowed clonal derivation of 
hESCs from a single blastomere (5).  
1.1.2 Human induced pluripotent stem cells 
The generation of induced pluripotent stem cells (iPSCs) from mouse embryonic and adult 
fibroblasts was first described in 2006 (24). Takahashi et al. demonstrated that forced 
expression of specific transcription factors reprogrammed adult fibroblasts into iPSCs that 
were remarkably similar to ESCs in gene expression profile, self-renewal and differentiation 
potential. In an elegant screen of 24 candidate genes, a set of four factors was identified 
essential for the generation of iPSCs: Pou5f1, Sox2, Krueppel-like factor 4 (Klf4), and v-Myc 
myelocytomatosis avian viral oncogene homolog (c-Myc). Shortly after, these same factors 
were used for the derivation of human iPSCs (25). Around the same time, another group 
reported independently the use of POU5F1, SOX2, NANOG and LIN28 for human iPSC 
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reprogramming (26). In a short amount of time, numerous studies aimed at optimizing iPSC 
generation from various somatic cells have been published (Figure 1) (27).   
1.1.2.1 Methods for iPSC generation 
The original methods for human iPSC induction used retroviral or lentiviral vectors for gene 
delivery; however, this results in integration of the transgenes into the cell genome with risk 
of genomic instability and chromosomal aberrations (25, 26). In addition, the derivation and 
culture conditions were dependent on the use of mouse feeder cells. Several improvements 
for the reprogramming conditions have now been reported, in terms of higher efficiency, 
integration-free delivery, and feeder-free conditions.  
Non-integrating virus, such as Sendai virus, has been used for efficient reprogramming of 
iPSCs (28). The Sendai virus vectors are gradually depleted from the cells through several 
cell divisions, which result in transgene-free iPSCs. A similar strategy is deployed when 
using non-integrating episomal plasmids, which additionally eliminates the need for handling 
viruses (29, 30). In addition to the vector-based methods, direct transfection with mRNAs or 
proteins has also been reported, although these methods are labor intensive and are not 
commonly used (31, 32). 
Although the majority of iPSC reprogramming conditions use mouse feeder cells, some 
feeder-free reprogramming methods based on various matrices, including Matrigel and 
vitronectin, have been reported (33-36). These methods often result in less efficient 
reprogramming or are used together with transgene integrating methods. Reprogramming 
with Sendai virus and synthetic mRNAs in feeder-free conditions has been successful, 
however, the conditions were not xeno-free (37, 38). Only recently, iPSC reprogramming 
with episomal plasmids in feeder-free and xeno-free conditions using laminin-511 E8 
fragment and StemFit medium was reported; although this was inefficient and not completely 
chemically defined (39). Thus, combining an integration-free method with chemically 
defined, xeno-free and feeder-free condition is still a challenge. 
1.1.3 Primed and naïve pluripotent stem cells 
Human and mouse PSCs, including ESCs and iPSCs, have distinct molecular and biological 
characteristics. Human PSCs grow as flat colonies and require bFGF and transforming 
growth factor beta (TGFβ) for self-renewal, whereas mouse PSCs form compact dome-like 
colonies, depend on leukemia inhibitory factor (LIF) and bone morphogenetic protein (BMP) 
4 to proliferate, and have high clonal efficiency (40). Although both human and mouse PSCs 
express the core pluripotency genes, there are also differences in their expression profiles, e.g 
SSEA1 is expressed in mouse PSCs but not in human (3, 41, 42). Mouse epiblast stem cells 
(EpiSCs) derived from post-implantation epiblast, however, resemble human PSCs more 
closely in the culture requirements (43). Thus, it has been suggested that two distinct phases 
of pluripotency exist, with mouse PSCs representing a naïve state and mouse EpiSC and 
human PSCs representing a primed state (44).  
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1.1.3.1 Conversion from primed to naïve  
The naïve state of mouse PSCs can be stabilized by using dual inhibition of mitogen-
activated protein kinase kinase (MEK) and glycogen synthase kinase 3 (GSK3) together with 
leukemia inhibitory factor (LIF) (45). Further, EpiSCs can be converted to mouse ESC-like 
naïve state by using chemical compounds, including the MEK and GSK3 inhibitors (2i), 
alone or together with over expression of reprogramming genes, such as Klf4 (46-49). Based 
on these findings, human PSCs were converted into naïve-like cells using 2i/LIF together 
with genetic manipulation (50, 51). Recently, several groups have reported culture conditions 
based solely on chemical compounds that can support the establishment of naïve-like human 
PSCs (52-56). Each group used a different chemical cocktail and basal medium, resulting in 
substantial differences between the naïve-like cells from different groups (56). Although the 
transcriptional and epigenomic profiles of naïve-like human PSCs closely resembled the 
naïve mouse pluripotency, some differences remained, e.g. in X chromosome inactivation 
(XCI) (56). However, it is still unclear how naïve human pluripotency should be defined and 
examined. 
1.1.3.2 X chromosome inactivation 
In female mammalian cells, one copy of the two X chromosomes is inactivated in order to 
achieve dosage compensation to balance gene expression levels. XCI is an epigenetic process 
that is regulated by X inactive specific transcript (Xist), a long noncoding RNA that coats the 
X chromosome and triggers the silencing effect (57). In mouse embryos, XCI is first seen in 
the paternal X chromosome, which is subsequently reactivated in the preimplantation 
epiblast, thus, mouse ESCs derived from these cells have two active X chromosomes (40). In 
postimplantation epiblast, random XCI occurs and EpiSCs derived from these cells have XCI 
(40). Therefore, XCI status of mouse PSCs has been used to define naïve and primed states. 
Of note, XCI is erased again specifically in primordial germ cells (PGCs) during mouse 
embryonic development (58).  
The status of XCI in human embryos and PSCs is not as clear. Paternal XCI does not occur in 
early human embryo and XIST expression is seen in both X chromosomes of the ICM cells, 
despite their active status (59). hESCs derived from the ICM, can have active X 
chromosomes or XCI with or without XIST coating (40). Similarly, differences in the XCI of 
the human naïve-like cells were reported, even increased XIST expression was observed after 
the conversion to naïve-like cells (56). Taken these differences, active X chromosomes might 
not be a defining feature of naïve pluripotency in the human.  
1.2 GERM CELL DEVELOPMENT 
Germ cells are unique cells with a sole function to transmit genetic information between 
generations and thus, secure the survival of a species. Germ cell development is a complex 
process that starts early in embryonic development and continues through the reproductive 
life of the individual, resulting in mature sperm or oocytes. Little is known about the early 
germ cell development in human, due to the inaccessibility of the embryo and the scarcity of 
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the germ cell population at that time. Therefore, most of our knowledge is extrapolated from 
studies with mice. Continuous research is done in order to obtain detailed information on the 
molecular and cellular mechanisms controlling the fate of the germ cells throughout the long 
process of germ cell development.   
1.2.1 Specification and migration 
The specification events of human germ cells are unknown, as the studies would require 
embryonic day (E) 9–16 embryos and are therefore impractical. These events, however, are 
studied in detail in mice. Mouse germ cell precursors are specified on E6.25 from the 
proximal epiblast cells in response to BMPs from the extraembryonic tissues (60, 61). These 
few precursors generate a founder population of about 40 PGCs that are identified as AP 
positive cells in the posterior primitive streak in the extraembryonic mesoderm at E7.25 (62, 
63). At E8.0, PGCs are residing in the yolk sac mesoderm, close to the junction with the 
allantois (64). The corresponding developmental age of human embryos is 3–4 weeks, and 
the earliest human PGCs have been identified in the same location as mouse PGCs (65, 66). 
Similar to mouse, human PGCs were characterized as large round cells with large nucleus 
and positive for AP. At E8.5 for mouse and 5 weeks of development for human, the PGCs 
initiate their migration through the hindgut and its mesentery into the genital ridges. By E11.5 
for mouse and 6 weeks of development for human, most of the PGCs have arrived at their 
destination and colonized the developing gonads (Figure 2) (65-67).  
The migration of PGCs seems to be a complex process, depending on passive and active 
events, appropriate physical pathway and directional cues. In addition, the migratory PGCs 
must survive and proliferate to increase in number (66). Although the exact process of PGC 
migration is not known, the initial translocation of PGCs from the yolk sac into the hindgut 
epithelium is believed to be passive, aided by the morphogenetic rearrangements of the 
embryo (68). After this, PGCs may be capable for active migration, shown by the change in 
morphology from round cells into an irregular shape with protrusions and pseudopodia (65). 
The migration may be mediated by a chemotaxic factor, KIT ligand (KITLG), which is 
expressed by the somatic cells along the migratory pathway, while KIT is expressed in the 
PGCs (69, 70). This interaction may also have a critical role in the survival of PGCs, as down 
regulation of KITLG in extragonadal areas has been shown to promote apoptosis in mouse 
PGCs that failed to migrate correctly (71). Furthermore, apoptosis in mouse PGCs is 
mediated by the pro-apoptotic gene BCL2-associated X protein, which has been shown to act 
downstream of KIT (72). KITLG is expressed also by the autonomic nerve fibers of the 
dorsal mesentery, and human PGCs have been shown to be in close contact with them (73). 
Thus, it has been proposed that from 6 weeks of development, human PGCs travel along the 
developing nerve fibers into the gonads (70). However, further studies are needed to elucidate 
the complex mechanism of migration, survival and proliferation of PGCs.  
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Figure 2. Human primordial germ cell (PGC) development. Around 3–4 weeks of embryonic development, 
PGCs are residing in the yolk sac mesoderm, close to the junction with the allantois. Between 5–9 weeks of 
development, PGCs proliferate and migrate through the hindgut and its mesentery into the genital ridges and 
colonize the developing gonads. Around 9 weeks of development, PGCs start to differentiate to either oogonia or 
gonocytes depending on the gonadal sex. In female gonads, oogonia undergo mitotic proliferation forming 
clusters of cells that are connected by intercellular bridges and surrounded loosely by somatic cells. Around 10–
12 weeks of development, oogonia start to enter into meiosis, arresting at the end of the prophase I and become 
primary oocytes. In male gonads, gonocytes become enclosed within the testis cords and are mitotically active 
until 5 months of development, followed by decreased proliferation period for the duration of the fetal 
development. 
1.2.2 Colonization and sex determination 
Human PGCs proliferate during migration, but mostly after reaching the gonads, resulting in 
about 450,000 germ cells in female and 150,000 in male by 9 weeks of development (74). 
The factors regulating human PGC proliferation are largely unknown, although BMP4, LIF, 
bFGF and forskolin have promoted in vitro proliferation of human PGCs (75, 76). The PGCs 
maintain their bipotentiality until sex specific differences start to occur. The fate of the germ 
cells to form either oocytes or sperm is independent of the germ cell sex, but rather 
influenced by environmental cues from the fetal gonads (77).  
1.2.2.1 Gonadal sex determination 
Differentiation of the somatic cells in an XY gonad is induced by the expression of the Y 
chromosome linked gene, SRY, which upregulates SOX9 expression (78). The expression 
induces cellular and morphological changes, including the differentiation of Sertoli and 
Leydig cells, and the formation of testis cords; which are the precursors of the seminiferous 
tubules around 7–9 weeks of development. The morphological changes in an XX gonad are 
less profound and the molecular genetics involved are poorly understood, however, wingles-
type MMTV integration site family, member (WNT) 4 and R-spondin 1 pathway along with 
forkhead box L2 (FOXL2) expression have been associated with ovarian development (78). 
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In the ovary, germ cell cords are visible at 6 weeks of development, but become fragmented 
and pushed towards the periphery, resulting in the formation of medulla and a germ cell-rich 
cortex by 13 weeks of development.  
1.2.2.2 Oogonia 
After reaching the developing gonads, PGCs differentiate to either oogonia or gonocytes 
depending on the gonadal sex. Oogonia are formed around 9 weeks of development and 
undergo mitotic proliferation for several weeks, mostly forming clusters of cells that are 
connected by intercellular bridges and surrounded loosely by somatic cells (74, 79). Around 
10–12 weeks of development, oogonia start to enter into meiosis, arresting at the end of the 
prophase I and become primary oocytes (80). The period of mitotic proliferation and meiosis 
is overlapping, and a heterogeneous germ cell population is observed even until the fifth 
month of development, with meiotic entry mostly in the inner cortex and mitotic proliferation 
in the outer cortex (78, 81). An estimate of 7 x106 oocytes is formed during this time (81, 82). 
However, many of the oocytes in the nests undergo apoptosis during the follicle assembly 
that begins around 18 weeks of development and continues into the third trimester (79, 81, 
82). The oocyte nests are broken down and single oocyte becomes surrounded by 
pregranulosa cells, forming a primordial follicle. The primordial follicles constitute a pool of 
around 3 x105 oocytes at birth, with most remaining quiescent for several years (83). 
1.2.2.3 Gonocytes 
PGCs in the male gonad become enclosed within the testis cords and are called gonocytes 
thereafter. Gonocytes are mitotically active with the highest rates of proliferation observed 
between the third and fifth months of development, followed by decreased proliferation 
period for the duration of the fetal development, and a small increase in proliferation at 2.5–6 
months after birth (84). Gonocytes represent a heterogeneous cell population with varying 
expression profiles and can be divided further into three subpopulations: mitotic, and 
transitional 1 and 2 prespermatogonia (85). Around the second trimester, most but not all 
mitotic prespermatogonia start differentiating to transitional spermatogonia, which 
downregulate the expression of pluripotency markers and become mitotically quiescent (85). 
Gonocyte migration from the center of the cords to the basement membrane seems to be a 
prerequisite for their differentiation and has been proposed to be mediated by a transient KIT 
expression in translocating gonocytes, at least in rodents (85). The transitional 1 
prespermatogonia are mostly found in pairs, and transitional 2 in groups of cells 
interconnected through cytoplasmic bridges, similar to differentiating oogonia (74). 
Transitional 2 prespermatogonia that colonize the basement membrane are believed to 
establish the pool of spermatogonial stem cells (SSC) that maintain spermatogenesis in 
adulthood (85).  
1.2.2.4 Germ cell sex determination 
The molecular mechanism behind the control of sex-specific entry into meiosis has been 
extensively studied in mice. Two secreted molecules, retinoic acid (RA) and fibroblast 
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growth factor 9 (FGF9), seem to have key roles in this event (77). In the fetal ovary, RA 
induces the expression of stimulated by retinoic acid gene 8 (Stra8) in oogonia, and triggers 
their entry into meiosis. In the fetal testis, RA is actively degraded by cytochrome P450, 
family 26, subfamily b, polypeptide 1 (CYP26B1) resulting in low Stra8 levels and no 
meiotic entry. In addition, FGF9, produced by Sertoli cells in the fetal testis, has been shown 
to inhibit meiosis and maintain the expression of pluripotency markers (77). In humans, RA 
and STRA8 seem to be involved in the meiotic regulation in the fetal ovary; however, 
CYP26B1 function in fetal testis did not seem to be conserved (80, 86). Furthermore, factors 
triggering the mitotic arrest of prespermatogonia are still unknown for both human and 
mouse, although FGF9 has been suggested to have a role (77).    
1.2.3 Oogenesis and spermatogenesis 
1.2.3.1 Oogenesis 
Primordial follicles are recruited into the growing follicle pool continuously, just after follicle 
formation and until menopause. The recruitment rate of primordial follicles increases from 
birth until 14 years of age, when about 900 follicles are recruited every month, followed by 
slow decline in numbers with age (83). When less than about 1000 primordial follicles are 
left in the ovary, follicle development stops and women undergo menopause, at around 50 
years of age (83).  
 
Figure 3. Folliculogenesis. Primordial follicle, consisting of a single oocyte surrounded by pregranulosa cells, 
develops into primary follicle with differentiated granulosa cells. During secondary follicle development, 
multiple layers of granulosa cells are formed, and oocyte starts to grow in size and forms a surrounding zona 
pellucida layer. Theca cells surround the follicle while a fluid filled cavity (antrum) appears at early antral and 
antral stages of follicle development. At preovulatory stage, the outermost layer of granulosa cells is called mural 
cells, and specialized granulosa cells, called cumulus cells, surround the oocyte, which is now matured and 
competent to resume meiosis. 
The primordial follicle, containing a single oocyte, develops through primary and secondary 
stages into antral follicle, but at this stage, most of the follicles undergo atretic degeneration 
(87). It is not until puberty, when a group of about 10 antral follicles escape apoptosis via 
follicle stimulating hormone (FSH) signaling each month, and one dominant follicle 
continues to grow until preovulatory follicle, finally resulting in the ovulation of a matured 
oocyte competent for fertilization (Figure 3) (87). The entire growth phase from primordial 
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follicle to preovulatory follicle takes longer than 8 months, and the follicle grows in size from 
about 30 µm to 20 mm (87, 88). The longest time is taken in the primordial to primary, and 
primary to secondary follicle development, with more than 120 days spent on both steps, 
although the biggest growth in follicle size is observed after the antral follicle formation (87).     
During the follicle development, the oocyte grows in size and matures. The process is 
regulated by endocrine and paracrine factors, and junctional interactions with the surrounding 
somatic cells in the follicle (89). The oocyte itself seems to be largely orchestrating the 
follicle maturation, and at least two oocyte-secreted factors, growth differentiation factor 9 
(GDF9) and BMP15, have been directly implicated in the process (89). At the secondary 
follicle stage, oocyte grows in size, and has a huge rise in RNA and protein synthesis and in 
the number of cell organelles, accumulating molecules and organelles that are required for the 
development of the preimplantation embryo (88). In addition, the formation of zona pellucida 
(ZP) around the oocyte is observed at this stage, consisting of glycoproteins secreted by the 
oocyte, ZP1, ZP2 and ZP3. At the end of the antral follicle stage, oocyte has reached its final 
size of about 120 µm, and has become competent to resume meiosis.  
Once the primary oocyte, still arrested at meiosis I, has grown and matured, it resumes 
meiosis in response to luteinizing hormone (LH) surge (89). The chromosomes condense and 
are divided into two cells in asymmetric cell division, resulting in a large oocyte and a small 
polar body, which eventually degenerates (89). The meiotic maturation is complete upon 
arrest at metaphase of meiosis II, forming a secondary oocyte. Meiosis resumes again only 
after fertilization by sperm, resulting in the formation of second polar body and an oocyte 
with a haploid chromosome content, and the initiation of embryo development (88, 89).  
1.2.3.2 Spermatogenesis 
Spermatogenesis starts in early puberty and consists of cycles where SSCs or undifferentiated 
spermatogonia undergo mitotic and meiotic divisions and differentiate into spermatids. From 
each SSC, up to 16 spermatids are formed in a process lasting 74 days, which results in a 
highly efficient system producing an average of 60 million sperm per ml of ejaculate (90, 91). 
Although daily sperm production tends to decline with advancing age, sperm production 
continues throughout the adult male life (90). 
Spermatogenesis occurs within the seminiferous tubules, which consist of Sertoli cells and 
germ cells at different stages, surrounded by peritubular cells (Figure 4). Spermatogenesis is 
heavily dependent on gonadotrophins, which affect the germ cells through the somatic cells 
found in the testis (92). LH induces the Leydig cells, located in the interstitial space, to 
produce testosterone, and Sertoli cells express receptors for both testosterone and FSH. 
Sertoli cells are the only somatic cells in the tubules and have several important roles in 
spermatogenesis. They nurture and maintain cellular associations with germ cells throughout 
the process of spermatogenesis, until the controlled release of mature spermatids into the 
tubular lumen (93). Sertoli cells also secrete several proteins and growth factors, such as glial 
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cell line derived neurotrophic factor (GDNF) and bFGF, which have been shown to promote 
SSC proliferation, and RA, which induces meiosis (94).  
 
Figure 4. Spermatogenesis. Spermatogenesis occurs within the seminiferous tubules, which consist of Sertoli 
cells and germ cells at different stages and a fluid filled lumen, surrounded by peritubular cells. Adark and Apale 
spermatogonia are located on the basement membrane of the tubule. Apale spermatogonia differentiate to type B 
spermatogonia, which divides by mitosis forming primary spermatocytes that enter into meiosis. Primary 
spermatocytes, connected by intercellular bridges, grow in size and move toward the lumen, forming secondary 
spermatocytes after completion of meiosis I. Secondary spermatocytes are smaller in size and proceed through 
meiosis II, forming haploid round spermatids, which are then transformed into spermatozoa and released into the 
lumen.  
Undifferentiated spermatogonia are semicircular in shape and are located on the basement 
membrane of the seminiferous tubules. They can be divided into two groups, named Adark and 
Apale based on the staining intensity with hematoxylin (95). Adark spermatogonia are relatively 
quiescent, while Apale are mitotically active and differentiate to type B spermatogonia. The 
Adark and Apale spermatogonia are considered to represent reserve and active SSCs, 
respectively, although the identity of human SSCs is not well established (95). Type B 
spermatogonia divide by mitosis forming two cells that enter into meiosis, now called 
primary spermatocytes (93). Once the primary spermatocytes progress through the prophase I 
stages of meiosis I, they become larger in size and move towards the lumen. Secondary 
spermatocytes are formed after completion of meiosis I, are smaller in size and go directly 
into meiosis II, forming haploid round spermatids (93). During the mitotic and meiotic 
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divisions, the daughter cells stay bound together through intercellular cytoplasmic bridges, 
enabling highly synchronized events (90).  
In the following several weeks, the round spermatids are transformed into spermatozoa in a 
process called spermiogenesis, which is actively guided by the Sertoli cells and resulting in 
the release of maturing spermatozoa into the lumen (90). The spermatids undergo a dramatic 
decrease in size by chromatin and nuclear condensation and reduction in the volume of 
cytoplasm, and change in morphology by acquiring an acrosome cap and a tail (93). Once the 
spermatozoa are released to the tubule lumen, they progress through the epididymis and 
mature to functional sperm able to move and fertilize an oocyte (96).     
1.3 GERM CELL RELATED GENES 
The characterization and identification of germ cells at different developmental stages is 
heavily relying on protein expression analysis. In mice, the germ cell development is 
relatively synchronized, whereas in humans, a more heterogeneous cell population is 
observed during fetal development that can only be identified through molecular markers. 
The expression pattern of commonly used markers for germ cells at different stages is 
discussed in the following section. In addition, the known functions of genes required for 
mouse germ cell development are described and compared to human germ cells.   
1.3.1 Specification genes 
The key regulators for mouse PGC specification, starting at E6.25, are identified as PR 
domain containing 1 (Prdm1, also known as Blimp1) and PR domain containing 14 (Prdm14) 
that are induced by BMP4 (97). PRDM1 induces the expression of transcription factor AP-2 
gamma (AP2γ) at E6.75, and together these three genes are required for PGC specification in 
mice (98). The expression of interferon induced transmembrane protein 3 (IFITM3) is also 
induced by BMP4 at E6.25 in the germ cell precursors, with increased expression at E7.0 in 
the PGCs relative to surrounding somatic cells, however, IFITM3 is suggested to aid early 
migration of PGCs rather than their specification (99-101). At E7.0, a germ cell specific 
expression of developmental pluripotency associated 3 (Dppa3, also known as Stella) is 
induced by PRDM1 and PRDM14, and it is often used as a first defining marker of specified 
PGCs (98, 99).   
PRDM1, PRDM14 and AP2γ expression in the mouse PGCs are continued during migration, 
until differentiation to gonocytes (102-104). The expression of these markers in early human 
PGCs is unknown, however, PRDM1 and AP2γ are reported to be expressed in 
PGCs/gonocytes at around 12–22 weeks of human development (105-107). Thus, suggesting 
that these genes may have a conserved role in human PGC specification. The expression of 
PRDM14 in human germ cells is not studied, however, it is highly expressed in hESCs and 
suggested to be involved in the maintenance of pluripotency by suppressing differentiation 
(108).  
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1.3.2 Pluripotency genes 
During mouse embryonic development, pluripotency-associated genes are expressed in the 
ICM and in the epiblast, but are subsequently restricted to the early germ cell lineage. Pou5f1 
expression is restricted to mouse PGCs from around E7.5 onwards and the expression is 
maintained until the onset of meiosis in both male and female germ cells, and re-expressed in 
oocytes after birth (109, 110). Pou5f1 expression is required for PGC survival and it has also 
been suggested to be required for PGC specification (111, 112). The expression of Nanog and 
Sox2, is first repressed, but induced again around E7.5 in mouse PGCs with continued 
expression until initiation of meiosis in female gonads or until mitotic arrest in male gonads 
(113, 114). Nanog expression is not detected in adult testes or ovaries; however, Sox2 is re-
expressed again in primary oocytes. Moreover, Nanog and Sox2 have been shown to be 
necessary for PGC development and maintenance (115-117).  
The expression of POU5F1 and NANOG is detected also in human migratory PGCs and 
undifferentiated gonocytes or oogonia, however, in contrary to mice, no SOX2 expression 
was found (70, 118-120). In addition, mouse SSCs in adult testis are expressing POU5F1, but 
no positive cells were found in adult human testis (121). Other pluripotency genes are also 
expressed in undifferentiated human germ cells, including LIN28 and SSEA4, whereas the 
expression of TRA1-60 or TRA1-81 was not observed (118, 119, 122). However, another 
study reported the expression of TRA1-81 in POU5F1 positive germ cells (123).  
The expression of KIT is detected in human germ cells during both fetal and postnatal 
development, and it is also expressed in hESCs (8). KIT is expressed already in migratory 
PGCs at 5 weeks of development with continued expression in gonocytes and oogonia, 
although showing heterogenous expression patterns with other gonocyte/oogonia markers 
(70, 118, 119, 123, 124). In ovaries, the oocytes in primordial follicles are negative, but start 
re-expressing KIT at primary follicle stage (73). In adult testis, KIT is expressed in 
spermatogonia and in the acrosomal region of round spermatids (125). 
Although SSEA1 is expressed in mouse embryonic stem cells (mESCs) and not in hESCs, 
both mouse and human PGCs are positive for SSEA1 (3, 41, 126). SSEA1 is expressed in 
human migratory PGCs, gonocytes, and oogonia until the onset of meiosis, although some 
SSEA1 positive cells did not express other germ cell related markers, indicating that it is not 
a germ cell specific marker (118, 119, 123, 124). In adult human testis, SSEA1 expression 
was found in few type A spermatogonia (127).  
1.3.3 RNA-binding proteins 
The germ cell lineage is enriched with RNA-binding proteins (RBPs) that are specifically 
expressed in the testis and ovary (128). Several RBPs have been identified to contribute to the 
differentiation and maintenance of germ cell development in diverse model organisms (129). 
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1.3.3.1 NANOS homologs 
The NANOS gene family is highly conserved and localized to the germ cells among different 
species (130). Nanos was first discovered in Drosophila, where it functions in germ cell 
migration and maintenance by blocking apoptosis and differentiation (131-133). In mice, 
three Nanos homologs exist, from which Nanos2 and Nanos3 are important for germ cell 
development as elimination of the gene results in a complete loss of germ cells in males or 
both males and females, respectively (134). Nanos2 is predominantly expressed in male germ 
cells between E13.5 and E17.5, with continued expression in undifferentiated gonocytes and 
SSCs in adult testis (135, 136). NANOS2 functions as a translational repressor for Stra8, 
Synaptonemal complex protein (Scp) 3 and Deleted in azoospermia like (Dazl), thus, 
suppressing meiosis (136-138). Nanos3 is expressed in PGCs as early as E7.25 and until 
around E14.5 in female germ cells or in male germ cells throughout the fetal period with 
declining expression after E16.5 (139). Nanos3 maintains the PGC population during 
migration via suppression of apoptosis (134, 140). The expression of Nanos3 is resumed 
again in postnatal spermatogonia and continues to be expressed in undifferentiated 
spermatogonia in adults, with a suggested role in the maintenance of SSC population (139, 
141). 
Similar to mouse, the human NANOS1 is more ubiquitously expressed, while NANOS2 and 
NANOS3 are expressed specifically in germ cells (142). NANOS2 is expressed in the fetal 
testis around 14 weeks of development, with increased expression at 17-20 weeks (86). In the 
adult testis, NANOS2 is expressed in the spermatogonia, but also in spermatocytes and some 
round spermatids (143, 144). In contrary to mouse, NANOS2 expression is also detected in 
human fetal ovaries, although at lower levels compared to fetal testis (86, 142, 144).  
NANOS3 is expressed in fetal testes and ovaries from around 8 weeks of development, with 
highest expression around 14–16 weeks (86). The expression of NANOS3 seems to be largely 
coupled with POU5F1 and PRDM1 expression (123). In the adult testes, NANOS3 is 
expressed in spermatogonia, spermatocytes and round spermatids (142, 144). Although 
NANOS3 expression is not found in adult mouse ovaries, human oocytes are positive for 
NANOS3 in all stages of follicle development (142). 
1.3.3.2 DAZL 
DAZL belongs to the Deleted in Azoospermia (DAZ) gene family, which consists of two 
additional members: DAZ, a Y-chromosome gene cluster linked to infertility in men; and a 
highly conserved autosomal gene BOULE (145). DAZ is present only in humans and old 
world monkeys, and it is expressed solely in the testis; in spermatogonia and early 
spermatocytes, while BOULE is highly conserved and expressed in later stages of 
spermatogenesis (145, 146). In contrast, DAZL is expressed in both males and females in 
multiple stages of germ cell development (146). 
In mice, Dazl expression is initiated during PGC migration and continues to be expressed in 
both adult testis and ovaries (145, 147-150). Disruption of Dazl leads to apoptosis mediated 
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germ cell loss after PGC migration and defects in progression through meiosis (147, 149, 
151, 152). In addition, gonocytes in fetal testis fail to enter mitotic arrest with continued 
expression of pluripotency markers (153). To elucidate the function of DAZL, its possible 
mRNA targets have been studied and at least the binding to DEAD (Asp-Glu-Ala-Asp)-box 
polypeptide 4 (Ddx4) and Scp3 for promoting their translation has been confirmed (154, 155). 
In human, DAZL is expressed in the nucleus of germ cells in the 1st trimester, but relocates to 
the cytoplasm during 2nd trimester, around the time when POU5F1 expression is lost or 
meiosis is initiated (150, 156). In the adult, DAZL is expressed in spermatogonia, 
spermatocytes and post-meiotic cells in the testis, and in oocytes in the ovary (145, 150, 157). 
DAZL transcripts are also found in the ICM of blastocysts and in hESCs, although protein 
expression is not detected in hESCs (158, 159). 
1.3.3.3 DDX4 
The Drosophila gene vasa has a central role in germ cell specification and in adult 
gametogenesis, with a null mutation leading to female sterility (160, 161). The mouse vasa 
homolog Ddx4 (also called Mvh) is also specifically expressed in the germ cell lineage (162). 
DDX4 is expressed in both male and female gonads from around E11.5 until post-meiotic 
spermatids and primary oocytes. The disruption of Ddx4 results in delayed proliferation of 
PGCs and blocked spermatogenesis in meiosis for males, while females have normal fertility 
(163). Thus, although DDX4 is expressed in both male and female germ lines, its exact 
function is still unclear and may be different between the genders. 
In human, DDX4 expression is found around 7 weeks of development in migratory PGCs, 
with increased expression after colonizing the gonads and differentiation to oogonia and 
gonocytes (118, 119, 156, 164). In adult testis, cytoplasmic expression of DDX4 is detected 
in spermatogonia and with higher intensity in spermatocytes and spermatids (164). Similarly, 
oocytes in adult ovaries are positive for DDX4 with increasing intensity upon follicle 
development (164). 
1.3.4 Meiosis genes 
Meiosis is a germ cell-specific cell division, where one round of chromosome replication is 
followed by two rounds of cell divisions, resulting in daughter cells with half the number of 
chromosomes. The first meiotic division separates chromosome homologs to two cells, and 
the second meiotic division separates sister chromatids to two more cells (165). Both meiotic 
divisions can be further dived into prophase, metaphase, anaphase and telophase stages. The 
prophase I is the longest stage of meiosis, when chromosome homologs interact and form 
crossovers of DNA (165). The progression through prophase I can be visualized with a 
formation of specific protein structure, called synaptonemal complex (SC) (166).   
During the first stage of prophase I, called leptotene, SCP2 and SCP3 proteins attach to each 
pair of sister chromatids (166). During zygotene, the homologous chromosomes start pairing 
up in a zipper-like fashion and are held together by SCP1 protein (166). The formed SC is 
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fully formed along the lengths of the chromosomes at pachytene, and chromosomal 
crossovers can be detected by foci of MutL homolog 1 (167). During diplotene, the SC 
degrades and chromosomes remain attached from the crossover regions (167). For proper 
alignment of chromosomes and formation of crossovers, double strand breaks (DSB) in DNA 
are necessary. The DSB are protected by phosphorylated H2A histone family, member X, 
which has also been shown to cover the sex chromosomes that do not fully synapse during 
meiosis (168). 
1.4 GERMLINE STEM CELLS 
Germline stem cells (GSCs) are the adult tissue stem cells in the gonads that are committed to 
produce gametes. The GSCs are most extensively studied in the Caenorhabditis elegans 
gonads, Drosophila testes and ovary, and mice testes (169). Male GSCs are called SSCs and 
undergo continuous self-renewal and differentiation into mature spermatozoa in all species 
studied (170), whereas female GSCs, called OSCs, are rare across the species (171).  
1.4.1 Spermatogonial stem cells 
SSCs comprise a rare cell population in the testis that upon transplantation can repopulate the 
recipient basal membrane of the seminiferous tubules, giving rise to complete 
spermatogenesis in mice (172). SSC transplantation has been described in various different 
species, making it a golden standard to characterize the functionality of SSCs (173). 
Xenotransplantation of SSCs of various species, including human, into the testis of a donor 
mouse has been shown to support SSC maintenance and proliferation (174, 175). However, 
meiosis was not supported in the xenotransplantation assay, except for rat SSCs (176), most 
likely due to evolutionary differences between the species. The SSC transplantation technique 
offers great promise for studying the SSC characteristics and for treating male infertility. 
Expansion of the rare SSC population would be necessary for possible clinical use in the 
future. Although little is known about the self-renewal of mammalian SSCs, progress has 
been made to identify important signaling pathways. GDNF has been shown to be important 
for the maintenance and self-renewal of SSCs in mice (177). Long-term in vitro cultures were 
established using GDNF stimulation for mouse SSCs, which exponentially increased in 
numbers (178). In addition, bFGF has been thought to induce SSC self-renewal (179, 180). 
Using the same conditions as for mouse, human SSCs were successfully expanded in vitro, 
and were demonstrated to be functional by xenotransplantation even after prolonged culture 
periods (181, 182). However, additional studies are still needed to replicate these experiments 
and further characterization for the in vitro expanded SSCs should be performed.      
1.4.2 Oogonial stem cells 
It has long been accepted that the ovary of most mammalian species contains a fixed number 
of primordial follicles established before birth that declines with age, with no new oocytes 
formed in the adult life (183). The view of fixed ovarian reserve was challenged in 2004, 
when the existence of OSCs was proposed in adult mouse ovaries (184). The assumption was 
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based mainly on calculated rates of oocyte degeneration, which indicated that the follicle pool 
must be replenished continuously in adulthood. The authors suggested that the OSCs reside in 
the ovarian surface epithelium, however, in a subsequent study the authors identified bone 
marrow and peripheral blood as potential source for the OSCs (185). These findings were 
widely criticized in the field and considered to be open for alternative interpretations (186, 
187). To determine the dynamics of human ovarian reserve, extensive histological studies 
were performed for calculating the number of non-growing follicles in the ovary from 
conception to menopause. The resulted Wallace-Kelsey model supported the view on fixed 
ovarian reserve and provided no evidence of neo-oogenesis in normal human physiological 
ageing (83). 
Recently, new evidence for OSCs was reported. Cells isolated from neonatal and adult mouse 
ovaries were able to proliferate in vitro for several months, and were reported to undergo 
oogenesis upon transplantation into ovaries of infertile mice, and finally resulted in live 
offspring (188). Based on these results, another group published similar work done on adult 
mouse ovaries as well as human ovaries (189). Both of these reports were based on isolating a 
small population of cells from the ovaries using either magnetic-activated cell sorting or 
fluorescence-activated cell sorting (FACS) with a DDX4 antibody staining for cell surface 
expression of the protein. This method was in controversy with the previous knowledge of 
DDX4 expression, which is widely considered to be expressed in the cell cytoplasm (163, 
190). The established in vitro cultured mouse and human OSCs were reported to 
spontaneously differentiate into oocyte-like cells in culture, with even a formation of haploid 
cells (189). However, no polar body formation was shown, which is indicative of the 
completion of meiosis II and haploid status of oocytes (89). After injecting the human OSCs 
into an ovarian cortex piece and xenotransplanting the tissue into mice, the authors reported 
the formation of primordial follicles that consisted of OSC-derived oocyte and recruited 
granulosa cells from tissue origin (189). Another group, however, demonstrated through live 
cell imaging that the Ddx4-expressing cells from postnatal mouse ovaries did not contribute 
to oocytes during de novo folliculogenesis (191). Furthermore, the presence of functional 
OSCs in the adult ovary is in discrepancy with the fixed ovarian reserve and occurrence of 
menopause (83). It has been proposed that the exhaustion of oocytes even with the existence 
of OSCs, might be due to ageing of OSCs or the somatic cells in the ovary (192). A potential 
explanation is that the putative OSCs are not functional in normal physiology, but once 
isolated from their original niche and placed in a new environment, they are transformed 
active.  
The existence of OSCs is still unclear, however, the recent reports have raised the central 
dogma of fixed ovarian reserve in question. If proven true, OSCs could be a potential source 
for basic science to model germ cell development, thus enabling us to acquire a more 
comprehensive understanding of this process. Possible clinical applications of OSCs include 
fertility preservation or treatment for infertility (192).   
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1.5 GERM CELL DIFFERENTIATION FROM PLURIPOTENT STEM CELLS 
Differentiation of germ cells from human PSCs offers a promising strategy to examine 
several aspects of human germ cell development in vitro. First, identifying signaling 
pathways and growth factors that may influence germ cell development, especially PGC 
specification and meiotic entry. Second, studying the genetic requirements for germ cell 
development by over expression or silencing of candidate genes. Third, modeling infertility 
using patient specific iPSCs.   
Reports from several research groups suggest that human PSCs have the potential to 
differentiate to early pre-meiotic germ cells and in few studies, even to post-meiotic germ 
cells. Although progress has been made during the recent years, improvements for the 
efficiency and reproducibility of the differentiation are needed. 
1.5.1 Differentiation conditions 
1.5.1.1 Growth factors 
Human ESCs were shown to have the potential to differentiate towards the germ line in 2004, 
when expression of germ cell related markers was shown in spontaneous EB differentiation 
(193). This enabled the testing of different growth factors and signaling pathways that may 
influence human germ cell development. A central growth factor for mouse PGC 
specification, BMP4, was found to induce germ cell differentiation from hESCs (194). The 
role of BMP4 in human germ cell formation was further shown by studies using the BMP 
inhibitor NOGGIN, which reduced the germ cell differentiation (195, 196). Thus, BMP4 is 
one of the most widely used growth factors for germ cell differentiation. 
KIT signaling has also been suggested to play a role in human germ cell development, and 
hESCs differentiated on feeder cells lacking KITLG had less efficient germ cell formation 
(195). Influence of WNT3A for germ cell differentiation was also suggested through inhibitor 
studies, however, these findings remain to be verified (196). Other factors that are commonly 
used in germ cell differentiation are bFGF and RA, because of their role in SSC proliferation 
and induction of meiosis (197-201). Recently, the conditions used for mouse SSC culture, 
including bFGF and GDNF growth factors, were directly utilized for human PSC 
differentiation (202, 203). 
1.5.1.2 Differentiation format 
The EB differentiation format with or without supplemented factors is often used, however, a 
variety of other methods have also been reported. Adherent differentiation on gelatin-coated 
surfaces is used because the total yield of cells after differentiation is higher relative to EBs, 
and Matrigel is used mainly for better initial attachment of PSCs (159, 204-206). In addition, 
feeder layers that are used for the maintenance of PSCs have also been used for 
differentiation experiments (195, 197, 198, 202, 207). Induction of germ cells has also been 
attempted in co-cultures by using somatic cells that are usually in contact with in vivo germ 
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cells, such as fetal gonad stromal cells, porcine ovarian fibroblasts and human granulosa cells 
(124, 200, 201).  
Majority of the reported studies use the same condition throughout the differentiation, but 
few step-wise protocols have been described. The combination of differentiation inducing 
factors has been changed in a step-wise manner in an attempt to mimic in vivo germ cell 
development from PGC specification and proliferation to initiation of meiosis (196, 203, 
207). In addition to the changes in medium composition, differentiation format has also been 
changed from EB differentiation to adherent cultures, or into calcium alginate encapsulated 
cultures (196, 203). These complex studies, however, are often lacking detailed analysis of 
the cell population in each step, and the individual effects of growth factors are not tested. 
The reported differentiation protocols vary in formats, growth factors and durations (from a 
few days to more than 10 weeks), making the comparison between experimental conditions 
difficult. In addition, different strategies for determining the efficiency of differentiation are 
used between the studies, thus no conclusions for optimal conditions have been made.  
1.5.1.3 Isolation of putative germ cells   
Differentiation of PSCs results in a heterogeneous cell population. Therefore, isolation of the 
putative germ cells would be important for detailed characterization and further 
differentiation experiments. Isolation of cell populations with enriched expression of germ 
cell related markers were reported by using SSEA1, chemokine (C-X-C motif) receptor 4, or 
GDNF family receptor alpha 1 (198, 203, 204). However, these markers are not specific for 
germ cells. Using a combination of unspecific markers, such as SSEA1 and KIT, or TRA-1-
81 and KIT, results in a more homogenous cell population (124, 199). Another combination 
based on CD9 and CD49f expression and negative expression for CD90 and SSEA4 has also 
been reported (207). 
At the moment, there are no germ cell specific cell surface markers known. Therefore, 
reporter cell lines for intracellular germ cell markers would be a good alternative for isolating 
putative germ cell populations. PSC lines with POU5F1-enhanced green fluorescent protein 
(EGFP) constructs have been used, but because undifferentiated PSCs also express POU5F1, 
this approach is not ideal (196, 201). A more specific isolation of germ cells has been made 
by using DDX4-EGFP reporters (159, 205, 206).  
1.5.1.4 Meiosis in vitro 
Differentiation to early pre-meiotic cells is readily seen from PSCs, determined by gene and 
protein expression profiles. Recently, several groups have also reported the presence of a 
small population of meiotic cells and even post-meiotic cells, using various differentiation 
methods (159, 196, 199, 202-204, 206-208). Meiotic cells were identified by the presence of 
SC formation in meiotic spread preparations by staining for SCP3 protein (159, 196, 206, 
208). The percentage of cells with elongated SCP3 staining varied between 1% and 10%, 
however, they were evaluated and calculated manually, which may cause large variation 
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between studies. A total population of 150-200 cells was analyzed in these studies, thus, 1-20 
cells were found to have initiated meiosis. 
Differentiation to post-meiotic cells was determined by the presence of haploid cells (1N) 
using flow cytometer based DNA content analysis or DNA fluorescence in situ hybridization 
(FISH) for chromosome counting, and in some studies, by staining for post-meiotic male 
germ cell markers, such as ACROSIN and PROTAMINE 1 (159, 196, 199, 202-204, 206, 
207). Of note, there have been no reports about differentiation to post-meiotic oocyte-like 
cells. It is important to confirm the differentiation to post-meiotic cells by a combination of 
methods instead of relying on one, because only a fraction of the cells isolated as 1N by 
FACS were confirmed to have haploid status by FISH (206). Therefore, the efficiency of 
differentiation to post-meiotic cells is hard to determine, however, it seems to be extremely 
low.   
1.5.1.5 Transplantation assay 
Transplantation to seminiferous tubules and observing colony formation is used for the 
characterization of SSC status and the assay is considered to be the golden standard in the 
field (95, 173). Recently, human PSCs were transplanted to the seminiferous tubules of 
busulfan-treated mice for examining their germ cell differentiation potential in vivo (208-
210). Although extensive tumor formation in the interstitial space was observed in some 
cases, PSCs were able to colonize the basement membrane of the seminiferous tubules and 
differentiate into morphologically and immunohistochemically recognizable germ cells. They 
showed features resembling PGCs and gonocytes, however, no further differentiation was 
observed. This may be partly due to the limitations of the xenotransplantation assay to 
support meiotic progression.   
1.5.2 Genetic analysis of human germ cell differentiation 
In mice, considerable progress in determining the genes related to the germ cell development 
has been made through gene disruption studies (211). The function of these genes in human 
germ cell development is largely unknown and mutations correlating with human infertility 
are rarely found. Human PSCs provide a useful tool to study the genetic requirements for 
germ cell development through genetic modifications.  
The function of DAZL, DAZ and BOULE in human germ cell development was studied in 
hESCs by silencing and over expression (159). Silencing of DAZL resulted in reduced 
expression of DDX4, whereas over expression increased DDX4 expression, thus DAZL was 
found to function in PGC/gonocyte formation. Furthermore, over expression of DAZL, DAZ 
and BOULE induced meiosis and formation of haploid cells from hESCs, suggesting their 
role as meiotic regulators. Similar experiments with DDX4 over expression in human PSCs, 
promoted the differentiation to early germ cells as well as progression through meiosis (206). 
In another study, DDX4 was used in combination with POU5F1, SOX2, KLF4 and c-MYC to 
reprogram iPSCs (208). These cells had increased potential to differentiate to early germ cells 
in vitro, and in vivo by using the xenotransplantation assay.   
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Genetic studies of germ cell related genes using human PSCs may also provide information 
about commitment to other cell lineages. Silencing NANOS3 in differentiated hESCs resulted 
in reduced expression of germ cell-related genes, pluripotency markers and also ectodermal 
markers, while endo- and mesodermal genes were not affected (142). Suggesting that 
NANOS3 may be required for proper regulation of marker expression for germ cell 
development, but may also influence ectodermal differentiation. In contrast, over expression 
of DPPA3 in hESCs leads to downregulation of neural markers and upregulation of germ cell 
and endodermal markers (212). Another study also showed negative correlation between 
germ cell and neural cell differentiation, modulated by PRDM1 and SOX2 (106). Over 
expression of PRDM1 in hESCs promoted the differentiation to early germ cells, and 
suppressed the transcription of SOX2, whereas silencing of PRDM1 impaired germ cell 
differentiation and upregulated neural genes. Furthermore, over expression of SOX2 skewed 
the differentiation from germ cells to the neural lineage.    
1.5.3 Patient iPSC lines for modeling infertility 
The iPSC-technology is especially intriguing for the germ cell development studies. 
Derivation of iPSCs from patients with genetically caused infertility could be used as an in 
vitro model for human infertility that is often difficult to study using animals. Furthermore, 
germ cell differentiation from patient-specific iPSCs could lead to a new form of assisted 
reproductive technology in the future.  
The potential of human iPSCs to differentiate to germ cells was shown to be similar to hESCs 
in 2009, and has been well established since (124). The first patient-specific iPSC line to 
model infertility was derived from a Klinefelter syndrome (KS) patient, with 47,XXY 
karyotype (213). Genome-wide transcriptome analysis identified aberrantly expressed genes 
in KS iPSCs that were associated with autoimmune diseases, progesterone-mediated oocyte 
maturation and protein catabolic process, which could also be linked to the clinical features of 
KS. The derived lines had XCI, however, many of the differentially expressed genes that 
were up-regulated in KS iPSCs, were located on X chromosome, indicating that some genes 
might escape the XCI and cause an overdosage effect. Germ cell differentiation potential of 
the KS iPSCs was found to be similar to controls, when spontaneous or BMP4-induced 
differentiation was used. No further differentiation was attempted, although the defects in 
germ cell development might be prominent only at the onset of meiosis.  
The derivation of Turner syndrome iPSCs, with 45,X karyotype, was recently reported (210). 
Using a xenotransplantation assay, Turner syndrome iPSCs were capable of forming germ 
cell like cells (PGCLCs) in vivo, indicating that intact X chromosomes are not required for 
germ cell formation, but may be required for the maintenance of germ cells in adulthood, 
because of the observed infertility in Turner syndrome patients. In another study, iPSCs 
derived from infertile men with deletions in the Y chromosome AZF region, were shown to 
have defects in germ cell differentiation (209). These patient iPSCs formed fewer and poor-
quality PGCLCs both in vitro and in vivo after xenotransplantation.  
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1.5.4 Differentiation of naïve human PSCs 
PGCLCs differentiated from naïve mouse PSCs showed robust capacity for spermatogenesis 
after injection into testis, and formation of oocytes after injection into ovaries, resulting in 
healthy offspring (214, 215). In these groundbreaking studies, the mouse germ cell 
specification pathway was reconstituted in vitro, resulting in efficient PGCLC generation 
from mouse PSCs that had previously been challenging (216). Naïve mouse PSCs were first 
cultured in bFGF and Activin A for 48h to acquire competence for germ cell fate, followed 
by induction to PGC fate in EB cultures with BMP4 (215). A robust formation of PRDM1 
positive cells (around 40%), and PRDM1/DPPA3 positive cells (around 7%) was observed on 
day 4. This differentiation protocol, however, was only efficient for naïve PSCs and not for 
EpiSCs. 
The recent advances in the generation of naïve human PSCs enabled testing of the PGCLC 
induction protocol on human cells (217). Human PSCs with a NANOS3-mCherry knockin 
reporter were cultured in four-inhibitor-containing medium for conversion to naïve state. 
Following the PGCLC induction protocol, the cells differentiated efficiently (around 27 %) 
into NANOS3 and tissue non-specific alkaline phosphatase double positive PGCLCs. In 
contrast, using conventional primed hESCs, the PGCLC-induction efficiency remained low 
(0-5 %). Interestingly, even higher efficiency (around 46 %) was reached by omitting the 2-
day preinduction step, which was necessary for mouse PSCs. By a thorough study with 
PRDM1 knockout and SOX17 knockout NANOS3-mCherry hESCs, the authors concluded 
that SOX17 is a critical signaling component driving human PGC specification, and functions 
upstream of PRDM1 and NANOS3. In addition, the competence of human PSCs towards the 
germ line could be influenced by environmental factors.   
1.6 INFERTILITY 
Infertility is defined as the inability of a couple to conceive after one year of unprotected 
intercourse. It is a significant health problem that affects about 10-15% of reproductive age 
couples worldwide, with both male and female factors contributing to the prevalence of 
infertility (218). The advances in assisted reproductive technology, especially IVF and 
intracytoplasmic sperm injection (ICSI), have increased the chances of conception (219, 220). 
However, infertility treatments for those who have few or no germ cells are still largely 
ineffective.      
1.6.1 Klinefelter syndrome 
Azoospermia, defined as complete absence of sperm from the ejaculate, is present in about 
1% of all men and in 10–15% of infertile men (221, 222). The most common genetic cause of 
infertility is KS, occurring in 11% of azoospermic men (223). KS is a sex chromosomal 
aneuploidy with 80–90% of cases having one additional X chromosome resulting in a 
47,XXY karyotype, while the remaining cases having higher number of X chromosomes (e.g. 
48,XXXY) or mosaicism (46,XY/47,XXY) (224, 225). KS is characterized by small firm 
testes, androgen deficiency, azoospermia, gynaecomastia, and tall stature (226). In addition, 
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varying degree of behavioral and learning impairments have been associated with KS (227). 
Due to variation in the clinical presentation and relatively discrete symptoms, most of the KS 
cases are diagnosed at adulthood, when the men are seeking treatment for infertility, while 
only less than 10% are diagnosed before puberty (225). More than 95% of adults with KS 
have azoospermia and patients often have a severely impaired fertility even before puberty 
(228). However, KS patients may have focal spermatogenesis in the testis, enabling 
biological paternity by testicular sperm extraction and ICSI (229).     
Germ cell degeneration in KS patients starts already in the fetal period, progresses slowly 
during childhood, and accelerates during puberty (230). In adults, the testes have extensive 
fibrosis and hyalinization of the seminiferous tubules, hyperplasia of interstitium, and 
presence of immature Sertoli cells (230). It is unclear whether the extra X chromosome 
primarily affects the degeneration of the germ cells or the somatic cells of the testis. XCI, 
normally occurring in female cells, has also been shown for KS men (231). However, small 
part of the X chromosome can escape the XCI, which in KS men could result in overdosage 
of gene products that may compromise the testicular function. It has also been speculated that 
the XXY germ cells cannot complete meiosis and thus, focal spermatogenesis is only possible 
when the extra X chromosome is somehow lost from the germ cells, however, both normal 
and aneuploid spermatozoa have been reported (231). The underlying mechanisms for the 
germ cell depletion in KS patients remain unclear.    
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2 AIMS 
The general aim of this thesis was to elucidate the genetic requirements for human germ cell 
development using PSCs and to study the existence of human OSCs. 
The specific aims of the four projects were: 
I. To assess the differentiation potential of human iPSCs towards pre-meiotic and post-
meiotic germ cells 
 
II. To study the function of NANOS3 and DAZL in human germ cell development using 
hESCs 
 
III. To optimize a clinically relevant iPSC reprogramming method for the derivation of 
patient specific iPSC line from KS patients 
 
IV. To isolate and characterize putative OSCs from adult human ovaries 
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3 MATERIALS AND METHODS 
3.1 ETHICS 
3.1.1 Human subjects  
Human iPSC lines used in Project I were derived at the Stanford University, CA, USA with a 
written consent from the donor and with the approval from the Institutional Review Board 
(No. 10368). In project III, skin tissue was biopsied and iPSC lines were derived with a 
written consent from the donor and with the approval from the Stockholm Regional Ethics 
Board (Dnr: 2013/1132-32). hESC lines were used with the approval from the Stockholm 
Regional Ethics Board (Dnr: 454/02 and Dnr: 2013/666-32). In project IV, human ovarian 
cortical tissue was obtained with a written consent from the donor and with the approval from 
the Stockholm Regional Ethics Board (Dnr: 2010/549-31/2). 
3.1.2 Animal work 
In project II, hESCs were transplanted into busulfan treated mice at the University of 
Pittsburgh, PA, USA with the approval from the Institutional Animal Care and Use 
Committee (No. 14043505). In project III, human iPSCs were transplanted into mice with the 
approval from the Stockholm South Ethics committee (Dnr: 5126-11). In project IV, ovarian 
cells and tissue were transplanted into mice with the approval from the Regional Ethics 
committee of the University of Gothenburg (Dnr: 11-2013). 
3.2 CELL CULTURE 
3.2.1 Human PSC maintenance 
3.2.1.1 Project I 
Human PSCs were cultured on γ-irradiated MEFs using culture medium consisting of 
Dulbecco’s Modified Eagle Medium (DMEM)/F-12 or KnockOut-DMEM supplemented 
with 20 % KSR, 2 mM L-glutamine, 0.1 mM non-essential amino acids (NEAA), 0.1 mM 2-
mercaptoethanol (2me), and 10 ng/ml bFGF. Cells were passaged onto fresh feeders in small 
clumps using 1 mg/ml Collagenase IV. 
For feeder-free culture of PSCs, culture plates were coated with 1:30 dilution of Matrigel in 
KO-DMEM for 2 h at 37 °C or at least over night at 4°C. The above-mentioned medium was 
conditioned on MEFs for 24 h and used for culturing of human PSCs on Matrigel. Cells were 
passaged as above. 
3.2.1.2 Project II 
Human ESCs were cultured on Matrigel-coated plates using mTeSR1 medium. Cells were 
passaged as single cells using Accutase and plated with 5-10 µM Y-27632 (ROCKi), which 
was removed from the cultures the next day. 
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3.2.1.3 Project III 
Culture plates were coated with 10-20 µg/ml laminin-521 for 2 h at 37 °C or at least over 
night at 4°C. Human PSCs were cultured on laminin-521-coated plates using mTeSR1 or 
NutriStem medium. Cells were passaged as single cell using TrypLE Select.  
3.2.2 Human PSC differentiation 
3.2.2.1 Project I 
Human PSCs were plated onto Matrigel coated plates using differentiation medium 
consisting of KO-DMEM supplemented with 20 % FBS, 2 mM L-glutamine, 0.1 mM 
NEAA, 0.1 mM 2me, and with or without 50 ng/ml BMP4, -7, and -8b. Cells were 
differentiated up to 14 days and medium was changed once a week. 
3.2.2.2 Project II 
Human ESCs were differentiated on mouse feeder cells using SSC-medium, following 
previously published method (202). Soriano ES feeder cell line SNL 76/7 STO cells (SNL) 
were γ-irradiated and plated with a density of 52,000 cells/cm2. Human ESCs were collected 
as clumps using 1 mg/ml Collagenase IV and plated onto SNL-feeders using mTeSR1 
medium. The next day, medium was changed to SSC-medium, consisting of Minimum 
Essential Medium alpha (α-MEM) supplemented with 0.2 % w/v bovine serum albumin 
(BSA), 1x Glutamax, 10 mM N-2-hydroxtethylpiperazine-N-2-ethane sulfonic acid 
(HEPES), 50 U/ml and 50 mg/ml penicillin-streptomycin (penstrep), 50 µM 2me, 5 µg/ml 
insulin, 10 µg/ml holo-transferrin, 30 nM sodium selenite, 60 µM putrescine, 2.36 µM 
palmitic acid, 0.21 µM palmitoleic acid, 0.88 µM stearic acid, 1.02 µM oleic acid, 2.71 µM 
linoleic acid, 0.43 µM linolenic acid, 1 ng/ml bFGF and 20 ng/ml GDNF. The SSC-medium 
was gassed with 90 % N2, 5 % CO2, 5 % O2 gas mixture for 30s before changed to cells every 
two days. Cells were differentiated up to 14 days.  
3.2.3 Primary fibroblast derivation and culture 
In project III, skin tissue was biopsied with a 4 mm punch, and cut into small pieces after 
removal of the dermis. Tissue pieces were cultured in medium consisting of DMEM 
supplemented with 10 % FBS, and 50 U/ml and 50 mg/ml penstrep. The expanded fibroblasts 
were passaged with 0.05 % Trypsin.   
3.2.4 Ovarian cell culture 
Human and mouse ovarian cells isolated by FACS in project IV, were cultured on γ-
irradiated MEFs or on 0.1 % gelatin-coated plates using culture medium consisting of α-
MEM supplemented with 10 % FBS, 1 mM sodium pyruvate, 1x Glutamax, 0.1 mM NEAA, 
0.1 mM 2me, 1x N2-supplement, 50 U/ml and 50 mg/ml penstrep, 10 ng/ml LIF, 1 ng/ml 
bFGF, 40 ng/ml GDNF, and 10 ng/ml epidermal growth factor, as previously published 
(189). Cells were passaged using a short incubation with 0.05 % trypsin.  
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3.3 GENETIC MANIPULATION 
3.3.1 Lentiviral transduction  
In project I, lentiviral supernatant was produced in 293FT cells by transfecting the cells by 
lipofection with plasmid of interest and viral packaging constructs VSVG and Δ8.9. For 
generating DDX4-EGFP reporter cells, previously published pLVGV vector was used, which 
contains 2.5 kilobase (kb) DDX4 promoter region with fused EGFP followed by 1 kb three 
prime untranslated region, and a neomycin resistance gene (159). For over expression, 
previously published p2K7blas vector carrying DAZL, DAZ2 or BOULE open reading frame 
(orf) under the elongation factor 1-alpha promoter were used (159). 
Undifferentiated PSCs cultured on Matrigel were infected using the lentiviral supernatant and 
8 µg/ml polybrene for 24 h at 37 °C. Antibiotic selection of transduced cells was started 48 h 
after transduction, either with 200 ng/ml geneticin for 7 days (DDX4-EGFP), or with 2 µg/ml 
blasticidin for 3 days (over expression).    
3.3.2 PiggyBac plasmid lipofection 
PiggyBac transposase expression vector (pCX-IFP2) containing piggyBac (also known as 
IFP2) gene driven by the CMV early enhancer/chicken beta actin (CAG) promoter was 
constructed by subcloning BamHI fragment of pBSII-IFP2-orf into pCX-EGFP digested with 
EcoRI to replace EGFP with IFP2. 
The piggyBac transposon vectors were constructed to contain the orf of the gene of interest 
driven by CAG promoter and followed by internal ribosome entry site and puromycin 
resistance gene, located between the 5’ and 3’ long terminal repeat regions. NANOS3 and 
DAZL orfs were amplified by PCR using cDNA synthesized from human testis RNA as a 
template. EGFP orf was obtained from pEGFP-N1 plasmid. The orfs were cloned into the 
destination vector using the Gateway LR recombination system.   
In projects II and IV, cells were co-transfected with a piggyBac transposon and transposase 
vector in 1:1 ratio using Lipofectamine LTX. Antibiotic selection with 1 µg/ml puromycin 
was started 48 h after transfection and continued for 6 days.   
3.3.3 Episomal plasmid reprogramming 
In project III, episomal plasmids carrying p53 small hairpin RNA and POU5F1 (pCXLE-
hOCT3/4-shp53), SOX2 and KLF4 (pCXLE-hSK), and L-MYC and LIN28 (pCXLE-hUL) 
were used for reprogramming human fibroblasts into iPSCs, and plasmid carrying EGFP 
(pCXLE-EGFP) was used as a control for transfection (30). Fibroblasts (6 x105 cells) were 
electroporated with 1 µg of each reprogramming plasmid, using 100 µl tip Neon System with 
1650 V, 30 ms, 1 pulse settings. Transfected cells were plated onto non-coated culture plate 
with fibroblast culture medium for six days. Cells were collected with 0.25 % Trypsin and 
plated onto laminin-521 or Matrigel-coated plates with a density of 5 x 103 cells/cm2. The 
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following day, medium was changed to NutriStem or mTeSR1. The formed iPSC colonies 
were manually picked 23–40 days after transfection. 
3.4 DNA ANALYSIS 
3.4.1 Plasmid copy number  
In Project III, genomic DNA was collected from iPSCs using the DNeasy Blood and Tissue 
kit from Qiagen, and analyzed by quantitative PCR (qPCR) using SYBR Green technology 
and primers for Epstein-Barr virus nuclear antigen 1 and F-box protein 15 for detecting 
plasmid and genomic DNA, respectively. Standard curves were prepared from pCXLE-EGFP 
plasmid and hESC DNA for evaluating plasmid copy numbers per cell. Standard curves for 
3–30,000 copies of plasmid and genomic DNA were prepared based on estimated values of 
1.096e-21 g/bp and 3.0e9 bp/haploid human genome. 
3.4.2 Karyotyping 
In project III, human iPSCs were treated with 10 µg/ml colcemid for 5 h and collected with 
TrypLE Select. Cells were treated with hypotonic solution (0.4 % potassium chloride) for 40 
min and fixed with Carnoy’s fixative (1:3 acetic acid:methanol). Metaphase spreads and G-
banding analysis was performed at the Genetics Clinic at Skåne University hospital, Sweden, 
with at least 25 mitoses analyzed per sample. 
3.4.3 FISH 
Cells isolated by FACS after DNA content analysis in Project I, were attached to slides using 
cytospin. Cells were fixed with Carnoy’s fixative and dehydrated in alcohol series. FISH 
probe against chromosome 16 was denatured on slides at 85°C for 5 min and hybridized at 
37°C over night. Cover slip was applied to slides using mounting medium containing 4’,6-
Diamidino-2-phenylindole (DAPI) for counterstaining DNA. 
3.5 GENE EXPRESSION 
3.5.1 qPCR  
Total RNA was extracted using the RNeasy Mini kit from Qiagen or PicoPure RNA isolation 
kit from Life Technologies, with on-column DNase I treatment. Reverse transcription (RT) of 
RNA to cDNA was done using random hexamers and SuperScript III enzyme. In project I 
and IV, cDNA was preamplified using Taqman assays as primers in PCR reaction. Gene 
expression was quantified using Taqman assays and StepOnePlus Real-Time PCR system 
(Projects II-IV) or Biomark 48.48 dynamic array chip with Biomark machine (Project I). 
Relative quantity was determined with comparative Ct (threshold cycle) method (2-ΔΔCt).   
3.5.2 RNA sequencing  
In Project II, total RNA was extracted using the RNeasy Mini Kit with on-column DNase I 
treatment. cDNA library preparation, sequencing and basic data processing was done at the 
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National Genomics Infrastructure at SciLifeLab Stockholm, Sweden. cDNA libraries were 
sequenced with Illumina HiSeq2500. Sequence reads were mapped to human genome using 
Tophat, and counts (the number of sequences that map to each gene) were calculated using 
HTseq. Cufflinks was used to calculate the fragments per kilobase per million mapped reads.  
In Project IV, single cells were manually picked and cDNA libraries were created as 
previously described in detail (232). Single-end sequencing was performed on Illumina 
HiSeq2000 and sequence reads were mapped to the human genome using STAR. The reads 
per kilobase per million mapped reads were generated using rpkmforgenes software.  
3.5.3 RT-PCR  
In Project IV, total RNA was isolated using the RNeasy Mini Kit and cDNA was synthesized 
with iScript cDNA Synthesis Kit. RT-PCR was used with gene specific primers and product 
was run on agarose gel for semi-quantitative gene expression analysis. 
3.6 PROTEIN EXPRESSION 
3.6.1 Western blotting 
Protein lysates were prepared using radio-immunoprecipitation assay (RIPA) buffer and 
protease inhibitors. Protein concentration was determined by bicinchoninic acid (BCA) 
Protein Assay kit with BSA standards using NanoDrop. Samples were denatured using 2me 
or dithiothreitol and run with sodium dodecyl sulphate-polyacrylamide gel electrophoresis. 
After running, proteins were transferred using a wet transfer (Project I) or semi-dry (Projects 
II and IV) transfer method. Transferred blots were blocked using non-fat milk before 
incubation with primary antibodies. Secondary antibodies conjugated to horseradish 
peroxidase (HRP) were used. Enhanced chemiluminescence was used for detecting HRP 
signal using film development or digital imaging.  
3.6.2 Immunocytochemistry  
Cells were fixed with 4 % formaldehyde, and permeabilized with 0.3 % Triton X-100. 
Blocking was done with serum from the same species as the secondary antibody. Primary 
antibodies were incubated over night at 4°C and fluorescence conjugated secondary 
antibodies were incubated for 1h at room temperature. DAPI was used for counterstaining 
DNA. For AP staining, Alkaline Phosphatase Detection Kit from Millipore was used (Project 
III). 
3.6.3 Immunohistochemistry  
Cross sections of paraffin embedded tissue were deparaffinized in xylene and rehydrated 
through ethanol series. Antigen retrieval was done in sodium citrate buffer (pH 6) at 96°C, 
followed by peroxidase and serum blocking. Primary antibodies were incubated over night at 
4°C and HRP-conjugated secondary antibodies were incubated for 30 min, followed by 
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incubation with Tyramide Signal amplification Plus Fluorescein or Cy3 System from Perkin-
Elmer. Mounting medium with DAPI was used. 
3.6.4 Meiotic spreads 
Single cell suspension was incubated with hypoextraction buffer containing 30 mM Tris, 50 
mM sucrose, 17 mM citric acid, 5 mM ethylenediaminetetraecetic acid and protease 
inhibitors. Cell solution was mixed with 100 mM sucrose and either dropped or cytospun 
onto slides. Samples were fixed with formaldehyde and blocked with serum. Primary 
antibodies were incubated for 3h and fluorescence conjugated secondary antibodies for 1h. 
Mounting medium with DAPI was used. 
3.7 FACS 
3.7.1 DDX4-EGFP expression  
In project I, human PSCs transduced with DDX4-EGFP construct were collected after 
differentiation using Collagenase IV and TrypLE enzymes. Single cell suspension was 
obtained by filtering cell solution through a 40 µm cell strainer. Non-transduced cells were 
used as negative control and EGFP-positive cells were sorted based on fluorescence intensity 
using FACSAria II.  
3.7.2 DNA content analysis  
In project I, differentiated human PSCs were collected using Collagenase IV and TrypLE 
enzymes. Single cell suspension was obtained by filtering cell solution through a 40 µm cell 
strainer. Cells were fixed with 70 % ethanol for 1h and stained with 0.02 mg/ml propidium 
iodide in a solution containing 0.1 % Triton X-100 and 0.2 mg/ml RNase A. DNA content 
was assayed based on staining intensity for propidium iodide on a linear scale using 
FACSAria II. Gating for haploid DNA content was set by estimating the distance from the 
diploid and tetraploid cell peaks and using human semen sample as positive control.   
3.7.3 DDX4 expression  
In Project IV, human ovarian cortical tissue was prepared for FACS as previously described 
(233). Briefly, tissue was dissociated into single cells using 400 U/ml Collagenese IV and 1 
µg/ml DNase I incubation for 40min in 37°C, with either manual disruption or with 
GentleMACS tissue dissociator. Mouse tissue was dissociated by mincing and digestion with 
800 U/ml Collagenase IV and 1 µg/ml DNase I. Cultured human ovarian cells were 
dissociated into single cells using 10 min 1mg/ml Collagenase IV and 2 min TrypLE 
incubations. Cells were blocked with serum from the same species as the secondary antibody, 
incubated with DDX4 antibody for 20 min and with fluorescence conjugated secondary 
antibody for 20 min. 7-Aminoactinomycin D was used for dead cell discrimination. 
Secondary antibody only, and isotype samples were used as negative controls and cells were 
sorted based on fluorescence intensity using FACSAria II (mouse cells) or FACSAria III 
(human cells).  
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3.8 TRANSPLANTATION 
3.8.1 Xenotransplantation into seminiferous tubules  
In Project II, immunodeficient mice (NCr nu/nu) were treated with 40 mg/kg of busulfan to 
deplete germ cells. After five weeks or more, 1 x106 hESCs were injected into the 
seminiferous tubules via cannulation of the efferent ducts. After eight weeks, the testes were 
collected for whole mount staining or for paraffin embedding and cross sectioning.   
For whole mount staining, the seminiferous tubules were dispersed using 1 mg/ml 
Collagenase IV and DNase I, and fixed with 4 % formaldehyde. Primary antibody against 
primate testis cells and fluorescence conjugated secondary antibody were used for detecting 
human cells. For cross sectioning, testes were fixed with 4 % formaldehyde, dehydrated and 
embedded into paraffin. Serial cross sectioning and hematoxylin and eosin (HE) staining was 
done at the Department of Laboratory Medicine at Karolinska Institutet, Stockholm, Sweden.  
3.8.2 Teratoma assay  
In Project III, human iPSCs were detached as small cell clumps by manual scraping, and 
plated into ultra-low adhesion plates with mTeSR1 or NutriStem medium with 10	  μM Y-
27632 for 24 h. Cell suspension (approximately 1 x106 cells) was mixed with undiluted 
Matrigel and injected subcutaneously into SCID/Beige mice. Mice were sacrificed and 
tumors collected at 3–8 weeks after injection. Tumors were fixed in 4 % formaldehyde, 
dehydrated, embedded in paraffin and cross-sectioned for HE staining at the Department of 
Laboratory Medicine at Karolinska Institutet, Stockholm, Sweden. 
3.8.3 Ovarian cell transplantation  
3.8.3.1 Human cells 
Human ovarian cells labeled with EGFP (approximately 3,000 cells), were injected into 
human ovarian cortical tissue piece (2 x 2 x 1 mm). The tissue piece was xenografted under 
the kidney capsule of recipient SCID female mouse. Xenografts were collected 1 week, 2 
weeks or 4 weeks after transplantation, fixed in 4 % formaldehyde, dehydrated, and 
embedded in paraffin for cross-sectioning. Fluorescent images were taken before HE 
staining. 
3.8.3.2 Mouse cells 
Red fluorescent mouse ovarian cells from mTmG (membrane-targeted Tomato and Green) 
females were injected into ovaries of adult female mice treated sterile with busulfan (30 
mg/kg) and cyclophosphamide (120 mg/kg). Approximately 10,000 cells were injected into 
each three locations per ovary. The ovaries were collected 1 week, 2 weeks or 6 weeks after 
injection, fixed in 4 % formaldehyde, dehydrated, and embedded in paraffin for cross-
sectioning. Fluorescent images were taken before HE staining. 
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3.9 STATISTICS 
Statistical significance between two groups was tested using unpaired t-test. For comparing 
multiple groups, one-way Analysis of variance (ANOVA) or two-way ANOVA with 
correction for multiple comparisons were used. Testing was done with Prism6 software and 
significance was accepted at p < 0.05.  
Differential gene expression analysis for mRNA sequencing data was done using edgeR 
analysis and R software. Significance was accepted at false discovery rate < 0.05. 
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4 RESULTS AND DISCUSSION 
4.1 GERM CELL DIFFERENTIATION POTENTIAL OF IPSCS (PROJECT I) 
HESCs can differentiate to pre-meiotic germ cells in response to BMP stimulation, and to 
meiotic and post-meiotic germ cells by over expressing the intrinsic meiotic regulators, 
DAZL, BOULE and DAZ (159). In Project I, we followed the same experimental approach to 
evaluate the germ cell differentiation potential of human iPSCs reprogrammed from fetal 
fibroblasts: iPS(IMR90), and from adult fibroblasts: iHUF4, using two hESC lines as 
controls: H9 and HSF1. 
4.1.1 Pre-meiotic germ cells 
After 7 and 14 days of BMP4, -7 and -8b stimulation, hESCs and iPSCs had induced protein 
expression of germ cell markers DDX4 and DAZL, in similar levels between the cell lines. 
Interestingly, low expression of DDX4 or DAZL was also detected in undifferentiated iPSCs, 
indicating the presence of a subpopulation of cells expressing germ cell markers even in the 
undifferentiated culture conditions.  
Gene expression of germ cell related markers was variable between the cell lines. Interferon 
induced transmembrane protein 1 (IFITM1) expression was higher in iPSCs relative to 
hESCs at day 7, and in iHUF4 relative to the other cell lines at day 14 of differentiation, 
whereas PRDM1 expression was higher for HSF1 relative to H9 and iPS(IMR90) cell lines at 
day 7 of differentiation. Expression of PELOTA was similar between the cell lines after 
differentiation; however, higher expression was observed for undifferentiated iPSCs relative 
to hESCs. In addition, IFITM1 expression was higher for undifferentiated HSF1 and 
iPS(IMR90) cells relative to H9 and iHUF4 cells, and PRDM1 expression was lower in 
iHUF4 cells relative to the other undifferentiated cell lines.  
Cells were transduced with DDX4-EGFP construct and analyzed by flow cytometer after 7 
days of differentiation. Approximately 2 % DDX4-EGFP positive cells were observed for 
hESC lines and 5 % for iPSC lines. The DDX4-EGFP positive and negative cells were 
isolated by FACS, and DDX4 expression in positive cells was confirmed by 
immunocytochemistry. Gene expression analysis reveled that several germ cell related 
markers were enriched in the DDX4-EGFP positive population: DNA meiotic recombinase I, 
Nuclear receptor subfamily 6, group A, member 1, IFITM1, PRDM1, DPPA3, PELOTA and 
POU5F1, whereas markers for the other germ layers were only detected in the negative 
population: GATA binding protein 6, Actin alpha cardiac muscle 1, Neural cell adhesion 
molecule 1, and Keratin 7, type II. 
4.1.2 Meiotic germ cells 
Cells were transduced with over expression constructs for DAZL, BOULE and DAZ, and 
differentiated up to 14 days. Meiotic initiation was observed in all cell lines in a subset of 
cells by immunocytochemistry for SCP3 in meiotic spread preparations, with punctate 
 36 
staining pattern indicating early leptotene stage and elongated staining pattern indicating 
zygotene, pachytene or diplotene stages of meiotic prophase I. Similar percentage of cells 
with punctate staining was observed for H9, HSF1 and iPS(IMR90) cells (9.36 %, 7.88 %, 
and 7.13 %, respectively), whereas a higher percentage for iHUF4 cells was observed (20.86 
%). The percentage of cells with elongated staining was similar between H9 and iHUF4 (0.75 
% and 1.23 %), and HSF1 and iPS(IMR90) (4.13 % and 4.63 %). No elongated staining was 
found for differentiated cells without over expression, but surprisingly, a rare cell with 
elongated staining was observed in undifferentiated iPS(IMR90) and iHUF4 cultures.       
4.1.3 Post-meiotic germ cells 
The completion of meiosis and formation of haploid cells was assessed by DNA content 
analysis using FACS, followed by DNA FISH. Human semen sample was used to set FACS 
gating to correspond the 1N cell population, and a small percentage of cells (> 2 %) was 
isolated from differentiated hESCs and iPSCs. The haploidy of the sorted cells was tested by 
DNA FISH for chromosome 16; after over expression, 13–21 % of the cells had a single copy 
of chromosome 16, whereas no haploid cells were confirmed for cells differentiated without 
over expression.  
Perinuclear ACROSIN expression, characteristic for spermatids, was observed for 35–72 % 
of 1N sorted cells. The higher percentage of ACROSIN staining relative to haploid cells 
suggests that ACROSIN expression may precede completion of meiosis. This was further 
supported by the observed ACROSIN positive cells and lack of haploid cells in samples 
without over expression. Furthermore, the percentage of ACROSIN positive cells was higher 
in over expressed sample (72 %) relative to sample without over expression (31 %).      
4.1.4 Discussion 
The differentiation of human fetal somatic cell-derived iPSCs to early stage germ cells had 
been previously shown (124), however, the potential of adult somatic cell-derived iPSCs to 
generate germ cells had not been reported, nor had the ability of iPSCs (from fetal or adult 
sources) to differentiate to meiotic and post-meiotic germ cells. We showed that human fetal 
and adult somatic cell-derived iPSCs could differentiate to pre-meiotic germ cells in response 
to BMP-signaling, in a similar manner to hESCs. In addition, the over expression of DAZ 
family proteins in iPSCs, like in hESCs, induced the initiation of meiosis, and furthermore, 
the formation of haploid cells with characteristic staining of ACROSIN for spermatids. With 
these results (summarized in Figure 5), we show that iPSCs provide a useful platform to 
study human germ cell development. 
We observed some differences between iPSCs and hESCs: the expression of germ cell 
markers and elongated SCP3 staining in undifferentiated iPSCs, and a higher percentage of 
DDX4-EGFP cells from iPSCs relative to hESCs upon differentiation. Thus, our data suggest 
that germ cell differentiation may occur more spontaneously in iPSCs than in hESCs. This 
may be linked to induced expression of pluripotency markers, the process of reprogramming, 
or a preferential differentiation to germline rather than somatic cell lineages. However, 
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further studies with additional cell lines are needed to elucidate the differences between 
hESCs and iPSCs and the possible mechanisms behind them.  
 
Figure 5. Human induced pluripotent stem cells (iPSCs) formed pre-meiotic, meiotic and post-meiotic germ cells 
upon differentiation with bone morphogenetic proteins (BMPs). Human iPSCs transfected with DDX4-EGFP 
reporter construct formed 5 % positive cells, which expressed several pre-meiotic germ cell genes. Upon over 
expression of DAZL, BOULE and DAZ, human iPSCs entered into meiosis shown by punctate (< 21 %) or 
elongated (< 5 %) SCP3 staining pattern. In addition, a small percentage (< 2 %) of haploid (1N) cells were 
isolated by fluorescence-activated cell sorting (FACS), from which < 14 % were confirmed to be haploid by 
fluorescent in situ hybridization (FISH), and < 62 % had a perinuclear ACROSIN staining.   
4.2 FUNCTION OF NANOS3 AND DAZL (PROJECT II) 
The germ cell specific RBPs, NANOS3 and DAZL, are important for germ cell development 
in mice, however, their function in human is poorly understood. In Project II, we used hESCs 
as a tool to study the effects of NANOS3 and DAZL via over expression. We analyzed the 
cells cultured in pluripotency maintaining conditions, and after in vitro and in vivo germ cell 
differentiation.  
4.2.1 Pluripotency maintaining conditions 
Stable transfection of hESCs with piggyBac mediated genomic integration of over expression 
constructs was confirmed by qPCR, immunocytochemistry and Western blotting. Cells could 
be cultured in pluripotency maintaining conditions for several passages, while maintaining 
the over expression of NANOS3 or DAZL. Majority of the NANOS3 transfected cells 
(pbNANOS3) expressed NANOS3 protein and grew in colonies with similar morphology to 
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undifferentiated hESCs. For DAZL transfected cells (pbDAZL), we observed cells outside the 
colonies that stained positive for DAZL, while majority of the cells in the colonies seemed 
negative.   
The expression of POU5F1 and NANOG was similar in pbNANOS3 and pbDAZL cells 
relative to control cells transfected with an empty vector (pbMOCK). By 
immunocytochemistry, similar staining pattern of POU5F1 and NANOG was observed for 
pbNANOS3 and pbDAZL cells relative to pbMOCK cells, although pbDAZL cells outside the 
colonies were negative. 
Global transcriptional analysis by mRNA sequencing revealed very similar gene expression 
profiles of pbNANOS3 and pbDAZL cells relative to pbMOCK; four genes were up regulated 
in pbNANOS3 cells, and eighteen genes were up regulated and eight down regulated in 
pbDAZL cells. Among the up regulated genes in pbNANOS3 cells, Olfactomedin 2 (OLFM2) 
has been shown to mediate TGFβ response with possible role in cell migration (234, 235), 
and Protein kinase C substrate 80K-H (PRKCSH) has a role in inhibition of apoptosis and 
induction of cell proliferation (236). 
Among the up regulated genes in pbDAZL cells, IFITM3 and BMP7 are associated with pre-
meiotic germ cells (101, 237), and Huntingtin interacting protein 1 related (HIP1R), Inositol-
3-phosphate synthase 1 (ISYNA), and Jagged 2 (JAG2) are associated with meiotic or post-
meiotic germ cells (238-240). In addition, two of the up regulated genes have a role in cell 
cycle arrest: p53-induced death domain protein (PIDD1) and Reprimo (RPRM) (241, 242). 
Four out of the eight down regulated genes in pbDAZL cells have been shown to play a role 
in cell migration: Chemokine (C-F-C motif) ligand 5 (CXCL5), Gamma-aminobutyric acid A 
receptor, pi (GABRP), Family with sequence similarity 110, member C (FAM110C), and 
Lymphocyte cytosolic protein 1 (LCP1) (243-246). 
4.2.2 In vitro germ cell differentiation 
We followed the previously published method for in vitro germ cell differentiation using 
SSC-medium and SNL-feeders up to 14 days (202). We found the induction of germ cell-
related Promyelotic leukemia zinc finger ortholog (PLZF) and PRDM1, and down regulation 
of POU5F1 and NANOG in pbNANOS3, pbDAZL, and pbMOCK cells upon differentiation. 
In addition, NANOS3 expression was induced in pbDAZL and pbMOCK cells, whereas DAZL 
expression was down regulated in pbNANOS3 and pbMOCK cells upon differentiation.  
Notably, we also observed the induction of Paired box 6 (PAX6) and maintained expression 
of SOX2 in all cell lines, suggesting a heterogeneous differentiation towards the neural 
lineage, in addition to germ cells.  
Interestingly, we found that DAZL expression was significantly lower in undifferentiated 
pbNANOS3 cells, but higher at day 14 of differentiation, relative to pbMOCK. We also 
observed a lower PLZF and PAX6 expression in pbNANOS3 cells relative to pbMOCK cells 
at day 7 of differentiation, suggesting a delayed differentiation of pbNANOS3 cells. 
Furthermore, POU5F1 and NANOG expression persisted longer for pbNANOS3 and pbDAZL 
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cells relative to pbMOCK cells, suggesting either differentiation to PGCLCs or remaining 
undifferentiated cells.      
4.2.3 In vivo germ cell differentiation 
We tested the in vivo germ cell differentiation potential of pbNANOS3 and pbDAZL cells via 
xenotransplantation into the seminiferous tubules of busulfan treated mice, as previously 
described (208, 209). The xenografts were collected eight weeks after transplantation and 
human cells were identified in whole-mount staining by an antibody against primate testis 
cells, or in paraffin embedded cross sections by a human cell specific antibody against 
Nuclear mitotic apparatus protein 1. By whole-mount staining of pbDAZL-transplanted testis, 
we found six human cell-derived cell colonies, with characteristic features of spermatogonial 
cell colonies: ovoid shape cells with high nuclear to cytoplasmic ratio, connected by 
intercytoplasmic bridges. For pbNANOS3-transplanted testis, a clump of human cells lacking 
the spermatogonial features was observed, whereas no positive cells were found in the 
pbMOCK-transplanted testes.  
Majority of the xenografts had a dominating tumor component and at least one testis 
transplanted with pbNANOS3, pbDAZL, or pbMOCK cells had teratoma formation. The 
seminiferous tubules of the xenografts had a similar percentage of human cell colonization 
(2.4-8.7 %), and most of the colonized tubules were full of human cells. We did not, 
however, observe any human cells positive for DDX4, indicating that the naïve niche of the 
tubules may have been disrupted and therefore could not support the germ cell differentiation 
to DDX4 positive cells.  
4.2.4 Discussion 
We utilized hESCs as a platform to study the function of NANOS3 and DAZL via over 
expression. For NANOS3, we found candidate genes that could mediate the inhibition of 
apoptosis and induction of migration in germ cells that are known functions of Nanos3 in 
mice (134, 140). In addition, we found a delayed differentiation and prolonged expression of 
pluripotency markers in pbNANOS3 cells, suggesting a possible role for NANOS3 in 
suppression of differentiation, similar to Nanos in Drosophila (132, 133). For DAZL, we 
identified several candidate genes that may mediate its known functions in germ cell 
differentiation and cell cycle arrest (149, 152, 153). Furthermore, we found that pbDAZL cells 
formed spermatogonial cell-like colonies after xenotransplantation, supporting the role of 
DAZL in germ cell differentiation. In addition, we found a possible new function for DAZL 
in inhibition of cell migration.  
Based on these results, we propose a model summarized in Figure 6, for the NANOS3 and 
DAZL mediated functions in human germ cell development. We suggest that NANOS3 and 
DAZL have largely opposing functions in germ cell development, with NANOS3 inducing 
cell migration and suppressing differentiation, while DAZL suppresses cell migration but 
induces differentiation. In addition, our data suggest a possible regulation of DAZL 
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expression by NANOS3, however; further studies are needed to confirm the interaction and 
possible direct binding of NANOS3 to DAZL mRNA.  
 
Figure 6. Proposed model for NANOS3 and DAZL mediated functions in germ cell development. NANOS3 may 
function in inhibition of apoptosis, suppression of differentiation, and promoting cell migration, while DAZL 
may block cell migration and induce germ cell differentiation and cell cycle arrest. 
4.3 INTEGRATION-FREE IPSCS FROM KS PATIENT (PROJECT III) 
Improvements for iPSC reprogramming conditions are needed in order to establish safe, 
chemically defined, and xeno-free cells for translational and possible clinical applications. In 
Project III, we used non-integrating episomal plasmids for iPSC reprogramming, combined 
with chemically defined and xeno-free iPSC culture conditions. Furthermore, using the 
developed conditions, we reprogrammed patient-specific iPSCs from fibroblasts derived from 
KS patients to establish an in vitro model to study the effects of supernumerary X 
chromosome.   
4.3.1 Reprogramming on laminin-521 
We derived human dermal fibroblasts (HDFs) from skin tissue biopsied from healthy adult 
males, and tested the reprogramming efficiency in feeder-free conditions using episomal 
plasmids: pCXLE-hOCT3/4-shp53, pCXLE-hSK and pCXLE-hUL (30). HDFs were 
transfected with the episomal plasmids by electroporation and cultured in fibroblast culture 
medium for 6 days, before reseeding the cells onto laminin-521 or Matrigel coated plates. 
The following day, culture medium was changed to chemically defined and xeno-free 
NutriStem medium, and cells were transferred to low oxygen conditions, which has been 
shown to increase iPSC reprogramming efficiency and promote the derivation of female 
hESCs with active X chromosomes (247, 248). We observed several small cell colonies that 
were positive for AP, on both laminin-521 and Matrigel coated plates by 15 days after 
transfection. However, significantly higher reprogramming efficiency was calculated for 
laminin-521 relative to Matrigel coated plates: 0.52 % vs. 0.36 %, respectively (p < 0.05).  
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For further characterization of iPSCs, we picked single colonies from laminin-521 and 
expanded them further. The iPSCs grew as uniform monolayer with typical hESC-like 
morphology on laminin-521 (5). The loss of episomal plasmids was confirmed by qPCR 
analysis for genomic DNA and a normal karyotype was confirmed by G-banding. The 
pluripotency was confirmed by the expression of pluripotency genes and the formation of 
teratoma after injection into SCID mice.  
4.3.2 KS iPSCs 
We collected skin tissue from azoospermic men diagnosed with KS (47,XXY), and derived 
iPSCs by using the optimized laminin-521 reprogramming conditions. With a special focus 
on the XCI status, we analyzed the gene expression level of XIST. We found that the KS 
fibroblasts and KS iPSCs had a similar or higher level of XIST expression relative to female 
fibroblasts, indicating XCI. To confirm the XCI in KS iPSCs, we analyzed the expression of 
Histone H3 trimethylated Lysine 27, a repressive chromatin marker, by 
immunocytochemistry. We observed an accumulated positive signal in the nuclei of KS 
fibroblasts and KS iPSCs, further indicating an inactive X chromosome.  
4.3.3 Discussion 
We achieved an efficient reprogramming of integration-free iPSCs in combination with 
chemically defined and xeno-free laminin-521 and NutriStem medium, summarized in Figure 
7. The reprogramming efficiency using episomal plasmids was significantly higher on 
laminin-521 (0.52 %) relative to Matrigel (0.36 %) and higher than in the original report 
using mouse feeder cells (0.39 %) (30). Furthermore, the recently reported reprogramming 
efficiency with the same episomal plasmids but using laminin-511 E8 fragments was 
extremely low (0.077 %) (39). Thus, laminin-521 supports an efficient reprogramming of 
iPSCs. Indeed, another recent report described the use of laminin-521 in iPSC 
reprogramming, with an efficiency of 0.3 %; however, an excisable polycistronic lentiviral 
method was used, which requires an additional manipulation step to excise the vector for the 
derivation of transgene-free iPSCs (249). Our new reprogramming conditions provide critical 
improvements towards deriving clinically safe iPSCs in an efficient manner. However, 
further optimization for the primary fibroblast derivation and culture conditions are still 
needed in order to produce iPSCs with a completely xeno-free reprogramming process.   
We derived patient-specific iPSCs from fibroblasts of donors with KS. We showed that the 
derived KS iPSCs had XCI, suggesting that low oxygen condition may not promote X 
chromosome reactivation during reprogramming or that XCI may be a characteristic feature 
of XXY cells. In support of the latter hypothesis, one earlier report on KS iPSCs also 
described XCI for the cells (213), however, further studies are required to determine whether 
or not it’s possible to derive KS iPSCs with both X chromosomes active. Regardless, the KS 
iPSCs provide a useful model to study sex chromosome aneuploidy and the possible defects 
in germ cell differentiation.  
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Figure 7. Reprogramming of patient fibroblasts in clinically relevant culture conditions. Primary fibroblasts are 
transfected with episomal reprogramming plasmids and cultured on plastic with human dermal fibroblast (HDF) 
medium in normoxia for 6 days, until they are reseeded onto laminin-521 coated plates. On day 7, culture 
medium is changed to chemically defined and xeno-free NutriStem medium and cells are cultured in hypoxia 
until reprogrammed cell colonies are picked around day 23-40 for cell line expansion.  
4.4 CHARACTERIZATION OF PUTATIVE OSCS (PROJECT IV) 
A recent report has raised the central dogma of fixed ovarian reserve in question with the 
isolation of mitotically active and functional OSCs from adult human ovaries (189). In 
Project IV, we followed the reported protocol for the isolation of putative OSCs from human 
and mouse ovaries for further characterization by gene and protein expression analysis, and 
by transplantation assay.  
4.4.1 Isolation of cells with DDX4 antibody-based FACS 
In germ cells, DDX4 is expressed in the cytoplasm of the cell and therefore the use of DDX4 
as a cell surface marker for FACS is controversial. Regardless, similar to the previous report, 
we were able to isolate a small population of cells (12.5 % ± 4.03 %) from human ovarian 
cell preparation that appeared positive for cell surface expression of DDX4 relative to isotype 
and secondary antibody controls. However, we did not detect any DDX4 mRNA expression 
in the isolated “DDX4-positive” cells by qPCR or by single-cell mRNA sequencing, instead, 
we found that genes expressed in differentiated ovarian somatic cells were frequently 
detected. In addition, we did not detected any Ddx4 mRNA expression in the isolated 
“DDX4-positive” cells from mouse ovarian cell preparation, but we did detect the expression 
of Foxl2, a marker of granulosa cells, at similar levels to that of the ovary. When we tested 
the DDX4 antibody-based FACS method with mouse cells from organs that do not express 
DDX4 (liver, spleen, and kidney), we found that similar “DDX4-positive” cell population 
could be isolated. These results showed that the use of the DDX4 antibody in the FACS 
method does not select for DDX4-expressing cells.  
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4.4.2 Functional assay for putative OSCs 
We established in vitro cultures of the isolated “DDX4-positive” and “DDX4-negative” 
human ovarian cells as previously described (189). The cultured cells did not express DDX4 
by immunocytochemistry, however, we found that both the “DDX4-positive” and “DDX4-
negative” cells appeared positive using the DDX4 antibody-based FACS, further confirming 
the unspecificity of the reported FACS method. Although the “DDX4-positive” ovarian cells 
did not express DDX4, we tested whether they could still be functional OSCs and generate 
oocytes after transplantation, as previously described (189).  
We labeled the cultured “DDX4-positive” human ovarian cells with stable EGFP expression 
and injected them into human ovarian cortical tissue pieces, which were subsequently 
xenografted into SCID mice (Figure 8). We analyzed the grafts at 1, 2 or 4 weeks after 
transplantation and found EGFP-positive cells in the vicinity of the injection sites. However, 
we did not observe any EGFP-positive oocytes, indicating that the isolated “DDX4-positive” 
cells are not functional stem cells that can generate oocytes.  
The “DDX4-positive” cells isolated from ovaries of mTmG mice, with all cells carrying red 
fluorescence, were expanded in culture for functional testing. The cells were injected into 
mouse ovaries and analyzed at 1, 2 or 6 weeks after injection. Similar to the results with 
human ovarian cells, we did not observe any newly formed oocytes from the injected red 
fluorescent “DDX4-positive” cells.    
4.4.3 Discussion 
We showed that the use of DDX4 antibody in FACS, which is a key tool in purifying the 
reported OSCs, does not select for DDX4-expressing cells. Furthermore, we showed that the 
human and mouse ovarian cells isolated with this method, did not form oocytes after 
transplantation. Thus, the isolated cells are neither specific DDX4-expressing cells nor are 
they functional OSCs. In contrast to the previous report (189), we found no evidence for the 
existence of OSCs in adult human or mouse ovaries.  
 
Figure 8. Functional testing for oogonial stem cells (OSCs). Human ovarian cortical tissue was dissociated to 
single cells and putative OSCs were isolated by DDX4 antibody-based FACS for in vitro culturing. The cultured 
ovarian cells were labeled green with EGFP-plasmid transfection and injected into human ovarian cortical tissue, 
which was transplanted under the kidney capsule of a mouse. After 1–4 weeks, the transplanted tissue was 
collected for histological analysis, to assess whether or not green fluorescent oocytes were formed from the 
injected cells.   
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5 CONCLUSIONS 
In this thesis, we evaluated the germ cell differentiation potential of human iPSCs and used 
hESCs as a tool to study the function of germ cell specific RBPs: NANOS3 and DAZL. In 
addition, we optimized iPSC reprogramming method towards xeno-free and chemically 
defined conditions, and reprogrammed patient-specific iPSCs from infertile patients 
diagnosed with KS. Furthermore, we assessed the existence of OSCs in adult human ovaries. 
The main findings are listed below.   
• Human fetal- and adult somatic cell –derived iPSCs could differentiate to pre-meiotic 
germ cells in vitro, with similar or even higher efficiency than hESCs. In addition, by 
over expressing intrinsic meiotic regulators: DAZL, BOULE and DAZ, human iPSCs 
formed meiotic and post-meiotic haploid germ cells in vitro, in a similar manner to 
hESCs. These data show that human iPSCs, in addition to hESCs, offer a valuable 
tool to study human germ cell development in all differentiation stages. 
 
• Over expression of NANOS3 in hESCs induced the expression of genes that are 
associated with mediating TGFβ –signaling and cell migration, and inhibition of 
apoptosis. Furthermore, NANOS3 over expression delayed the in vitro differentiation 
of hESCs by maintaining the expression of pluripotency genes and suppressing the 
expression of differentiation genes. Thus, human NANOS3 protein may function in 
PGC migration, inhibition of apoptosis, and suppressing of differentiation that are all 
conserved functions of NANOS family proteins in different model organisms. 
 
• Over expression of DAZL in hESCs induced the expression of genes related to cell 
cycle arrest and germ cell differentiation, while several genes related to cell migration 
were down regulated. In addition, DAZL over expressed hESCs formed 
spermatogonial-like cell colonies after transplantation into the seminiferous tubules of 
mice. These data indicate that the known function of DAZL in germ cell 
differentiation and cell cycle arrest is conserved also in human. Furthermore, DAZL 
may also have a role in a novel function in inhibition of cell migration. 
 
• Laminin-521 and NutriStem medium supported an efficient reprogramming of iPSCs 
using integration-free episomal plasmids, providing critical improvements towards 
establishing clinically safe iPSCs. In addition, iPSCs from infertile KS patients were 
derived for future studies of X chromosome aneuploidy and defects in germ cell 
differentiation.  
 
• The DDX4 antibody –based FACS method for isolation of putative OSCs did not 
select DDX4-expressing cells. In addition, the isolated cells from adult human or 
mouse ovaries did not form oocytes after transplantation, indicating the cells are not 
functional OSCs. Thus, no supporting evidence for the existence of OSCs in adult 
human or mouse ovaries was found 
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6 FUTURE PERSPECTIVES 
Human germ cell specification and differentiation is poorly understood, which is largely due 
to the scarcity of PGCs and the inaccessibility of the early human embryos. Human PSCs 
offer a promising tool to model germ cell differentiation in vitro and to identify intrinsic 
genes regulating the germ cell development. We showed that both hESCs and iPSCs have the 
potential to differentiate to germ cells; however, the efficiency of differentiation is still low 
and results in a heterogeneous cell population. Fluorescence reporter constructs for germ cell 
–specific expression can be used to enrich for the differentiated germ cells and to isolate them 
for further experiments. In addition, the constructs could be used for identifying cell surface 
markers for the isolation of germ cells without genetic manipulation and for screening growth 
factors and small chemical libraries for more efficient germ cell differentiation. 
The initiation and progression through meiosis, a hallmark of germ cell development, is still a 
challenge for the in vitro differentiation of PSCs. Over expression of DAZL, BOULE and 
DAZ has been shown to induce meiosis in hESCs (159), and we confirmed the same effect for 
iPSCs. However, extremely low percentage of cells initiated or completed meiosis even with 
the over expression, which may be partly due to translational regulation of the DAZ family 
genes. We observed that hESCs transfected with a piggyBac over expression construct for 
DAZL had high expression of DAZL mRNA, while only a subpopulation of the cells 
expressed DAZL protein. In addition, undifferentiated hESCs have DAZL expression in 
mRNA level, but not in protein level, further confirming the translational regulation of DAZL 
in hESCs. Our over expression platform could be used for studying the mechanisms behind 
the regulation of DAZL, which could provide valuable insights for the control of germ cell 
differentiation.  
We suggested that the known functions of NANOS3 and DAZL in mice and other model 
organism might also be conserved in human germ cell development. In addition, we 
identified a possible novel function of DAZL in controlling cell migration. It seems that 
NANOS3 and DAZL may have largely opposing functions; NANOS3 mediates cell 
migration and suppresses differentiation, while DAZL inhibits cell migration and induces 
differentiation. We also found indications that NANOS3 may down regulate DAZL 
expression, which would further indicate their opposing roles in germ cell development. 
Additional in vitro and in vivo studies are needed to confirm these findings, and the candidate 
genes identified in our studies provide a good starting point.  
Cell transplantation into the germ cell –depleted seminiferous tubules of mice is often used 
for the functional testing of SSCs, in addition, it has recently been used to assess the germ 
cell differentiation potential of human PSCs (208-210). We found that after the 
xenotransplantation, hESCs over expressing DAZL formed spermatogonial-like cell colonies, 
which had not been achieved with hESCs before. The xenotransplantation assay provides an 
essential functional testing for germ cell differentiation; however, further optimization is 
needed in order to eliminate the extensive tumor formation from the transplanted PSCs. 
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Specifically, the optimal cell number and differentiation state of the cells should be 
determined.    
The development of iPSC technology has enabled the derivation of patient-specific iPSCs 
that can be used as an in vitro model for a disease or possibly in autologous cellular therapies. 
However, optimization of the reprogramming method is needed in order to produce clinically 
safe iPSCs. We achieved an efficient integration-free reprogramming of iPSCs using xeno-
free and chemically defined culture conditions, which provide critical improvements towards 
clinically safe iPSCs. For completely xeno-free reprogramming process, however, the 
derivation and culture conditions for patient fibroblasts must be modified to eliminate the use 
of animal-derived FBS and trypsin.  
We reprogrammed iPSCs from infertile patients diagnosed with KS (47,XXY) for 
establishing an in vitro model to study the effect of the supernumerary X chromosome for 
germ cell differentiation. The derived iPSCs had XCI, similar to the patient fibroblasts; 
however, it would be interesting to study the possible genes escaping the XCI and their role 
in germ cell differentiation. Further studies are needed in order to evaluate the in vitro germ 
cell differentiation potential of the KS iPSCs. The recent advances in converting human PSCs 
into a naïve state, similar to mouse PSCs, enabled efficient differentiation into germ cells (53, 
217). In addition, the naïve human PSCs had both X chromosomes active. Thus, it would be 
interesting to convert the KS iPSCs into a naïve state, and study their XCI status and germ 
cell differentiation efficiency. 
The recently reported OSCs from adult human ovaries could provide another potential cell 
source to study germ cells in vitro, however, the existence of OSCs is still unclear. There are 
several shortcomings in the previous report of human OSCs (189). First, the expression of 
DDX4 in the cell surface, a critical point in the isolation of the cells, was assumed and never 
tested. Second, the markers used to characterize the putative OSCs, are not specific to germ 
cells. Third, the formation of haploid oocytes was claimed without showing the indicative 
polar body formation. And fourth, the reported follicle-enclosed oocytes were shown to be 
GFP positive by antibody staining and not by native GFP expression. We showed that the 
DDX4 antibody –based isolation of putative OSCs was not specific for DDX4 expressing 
cells, and the isolated cells were not functional OSCs. Thus, no evidence for the existence of 
OSCs was found. More careful studies should be performed with stricter standards before 
characterizing cells as OSCs. 
In conclusion, the recent advances in human PSCs derivation, manipulation and 
differentiation have enabled new strategies to examine the human germ cell specification and 
differentiation events, and the genetic requirements of human fertility. In years to come, 
human PSCs could provide a source for a new form of assisted reproduction.  
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